Ziele
der
Studie
Aims of the study
Studienablauf
Study program
Nachbeobachtung
Follow-up
Studienregion
Study region
Ergebnisse
Results
Projektleitung
Principal investigators
Kooperationen
Cooperations
Förderung
Funding
Publikationen
Publications
Kontakt
|
 |
Publikationen
aus
der DACHS-Studie /
Publications from the DACHS study
2020
181. Amitay EL, Carr
PR, Jansen L, Roth W, Alwers E, Herpel E, Kloor M,
Bläker H, Chang-Claude J, Brenner H, Hoffmeister
M. Smoking, alcohol consumption and colorectal
cancer risk by molecular pathological subtypes and
pathways. Br J Cancer 2020 [Epub ahead of print].
180. Carr PR, Weigl K, Edelmann
D, Jansen L, Chang-Claude J, Brenner H,
Hoffmeister M. Estimation of absolute risk of
colorectal cancer according to a healthy
lifestyle, genetic risk, and colonoscopy status: a
population-based study. Gastroenterology 2020
[Epub ahead of print]
179. Xia Z, Su YR,
Petersen P, Qi L, Kim AE, Figueiredo JC, Lin Y,
Nan H, Sakoda LC, Albanes D, Berndt SI, Bézieau S,
Bien S, Buchanan DD, Casey G, Chan AT, Conti DV,
Drew DA, Gallinger SJ, Gauderman WJ, Giles GG,
Gruber SB, Gunter MJ, Hoffmeister M, Jenkins MA,
Joshi AD, Le Marchand L, Lewinger JP, Li L, Lindor
NM, Moreno V, Murphy N, Nassir R, Newcomb PA,
Ogino S, Rennert G, Song M, Wang X, Wolk A, Woods
MO, Brenner H, White E, Slattery ML, Giovannucci
EL, Chang-Claude J, Pharoah PDP, Hsu L, Campbell
PT, Peters U. Functional informed genome-wide
interaction analysis of body mass index, diabetes
and colorectal cancer risk. Cancer Med 2020 [Epub
ahead of print]
178. Zhang Y, ..., Chatterjee N. Assessment of
Polygenic Architecture and Risk Prediction based
on Common Variants Across Fourteen Cancers. Nat
Commun 2020, accepted
177. Campbell PT, Yi Lin, Stephanie A Bien, Jane C
Figueiredo, Tabitha A Harrison, Mark J Guinter,
Sonja I Berndt, Hermann Brenner, Andrew T Chan,
Jenny Chang-Claude, Steven J Gallinger, Susan M
Gapstur, Graham G Giles, Stephen B Gruber, Marc
Gunter, Michael Hoffmeister, Eric J Jacobs, Mark A
Jenkins, Loic Le Marchand, Li Li, John R
McLaughlin, Neil Murphy, Roger L Milne, Polly A
Newcomb, Christina Newton, Shuji Ogino, John D
Potter, Gad Rennert, Hedy S Rennert, Jennifer
Robinson, Lori C Sakoda, Martha L Slattery, Yiqing
Song, Emily White, Michael O Woods, Graham Casey,
Li Hsu, Ulrike Peters. Association of body mass
index with colorectal cancer risk according to
genome-wide variants. J Natl Cancer Inst 2020,
accepted
176. Phipps AI*, Alwers E*, Harrison T*, Banbury
B, Brenner H, Campbell PT, Chang-Claude J,
Buchanan D, Chan AT, Farris AB, Figueiredo JC,
Gallinger S, Giles GG, Jenkins M, Milne RL,
Newcomb PA, Slattery ML, Song M, Ogino S, Zaidi
SH, Hoffmeister M*, Peters U* (shared first and
last authorships). Association Between Molecular
Subtypes of Colorectal Tumors and Patient
Survival, Based on Pooled Analysis of 7
International Studies. Gastroenterology 2020 [Epub
ahead of print]
175. Amitay EL, Carr PR, Jansen L, Alwers E, Roth
W, Herpel E, Kloor M, Bläker H, Chang-Claude J,
Brenner H, Hoffmeister M. Postmenopausal hormone
replacement therapy and colorectal cancer risk by
molecular subtypes and pathways. Int J Cancer 2020
[Epub ahead of print]
174. Peng L, Balavarca Y, Niedermaier T, Weigl K,
Hoffmeister M, Brenner H. Risk-Adapted Cutoffs in
Colorectal Cancer Screening by Fecal
Immunochemical Tests. Am J Gastroenterol 2020
[Epub ahead of print]
173. Thong MSY, Jansen L, Chnag-Claude J,
Hoffmeister M, Brenner H, Arndt V. Association of
laparoscopic colectomy versus open colectomy on
the long-term health-related quality of life of
colon cancer survivors. Surg Endosc 2020 [Epub
ahead of print]
172. Eyl RE, Koch-Gallenkamp L, Jansen L, Walter
V, Carr PR, Hoffmeister M, Chang-Claude J, Brenner
H, Arndt V. Physical activity and long-term
quality of life among colorectal cancer survivors
- a population-based prospective study. Cancer
Prev Res (Phila) 2020 [Epub ahead of print]
171. Khankari NK, Banbury BL, Borges MC, Haycock
P, Albanes D, Arndt V, Berndt SI, Bézieau S,
Brenner H, Campbell PT, Casey G, Chan AT,
Chang-Claude J, Conti DV, Cotterchio M, English
DR, Figueiredo JC, Giles GG, Giovannucci EL,
Gunter MJ, Hampe J, Hoffmeister M, Hopper JL,
Jenkins MA, Joshi AD, Le Marchand L, Lemire M, Li
CI, Li L, Lindblom A, Martín V, Moreno V, Newcomb
PA, Offit K, Pharoah PDP, Rennert G, Sakoda LC,
Schafmayer C, Schmit SL, Slattery ML, Song M,
Thibodeau SN, Ulrich CM, Weinstein SJ, White E,
Win AK, Wolk A, Woods MO, Wu AH, Cai Q, Denny JC,
Edwards TL, Murff HJ, Gruber SB, Peters U, Zheng
W. Mendelian randomization of circulating
polyunsaturated fatty acids and colorectal cancer
risk. Cancer Epidemiol Biomark Prev
2020;29(4):860-870
170. Murphy N, Carreras-Torres R, Song M, Chan AT,
Martin RM, Papadimitriou N, Dimou N, Tsilidis KK,
Banbury B, Bradbury KE, Besevic J, Rinaldi S,
Riboli E, Cross AJ, Travis RC, Agnoli C, Albanes
D, Berndt SI, Bézieau S, Bishop DT, Brenner H,
Buchanan DD, Onland-Moret NC, Burnett-Hartman A,
Campbell PT, Casey G, Castellví-Bel S,
Chang-Claude J, Chirlaque MD, Chapelle A, English
D, Figueiredo JC, Gallinger SJ, Giles GG, Gruber
SB, Gsur A, Hampe J, Hampel H, Harrison TA,
Hoffmeister M, Hsu L, Huang WY, Huyghe JR, Jenkins
MA, Keku TO, Kühn T, Kweon SS, Le Marchand L, Li
CI, Li L, Lindblom A, Martín V, Milne RL, Moreno
V, Newcomb PA, Offit K, Ogino S, Ose J, Perduca V,
Phipps AI, Platz EA, Potter JD, Qu C, Rennert G,
Sakoda LC, Schafmayer C, Schoen RE, Slattery ML,
Tangen CM, Ulrich CM, van Duijnhoven FJ, Van
Guelpen B, Visvanathan K, Vodicka P, Vodickova L,
Vymetalkova V, Wang H, White E, Wolk A, Woods MO,
Wu AH, Zheng W, Peters U, Gunter MJ. Circulating
Levels of Insulin-like Growth Factor 1 and
Insulin-like Growth Factor Binding Protein 3
Associate With Risk of Colorectal Cancer Based on
Serologic and Mendelian Randomization Analyses.
Gastroenterology 2020;158(5):1300-1312
169. Archambault AN, Su YR, Jeon J, Thomas M, Lin
Y, Conti DV, Win AK, Sakoda LC, Lansdorp-Vogelaar
I, Peterse EF, Zauber AG, Duggan D, Holowatyj AN,
Huyghe JR, Brenner H, Cotterchio M, Bézieau S,
Schmit SL, Edlund CK, Southey MC, MacInnis RJ,
Campbell PT, Chang-Claude J, Slattery ML, Chan AT,
Joshi AD, Song M, Cao Y, Woods MO, White E,
Weinstein SJ, Ulrich CM, Hoffmeister M, Bien SA,
Harrison TA, Hampe J, Li CI, Schafmayer C, Offit
K, Pharoah PD, Moreno V, Lindblom A, Wolk A, Wu
AH, Li L, Gunter MJ, Gsur A, Keku TO, Pearlman R,
Bishop DT, Castellví-Bel S, Moreira L, Vodicka P,
Kampman E, Giles GG, Albanes D, Baron JA, Berndt
SI, Brezina S, Buch S, Buchanan DD, Trichopoulou
A, Severi G, Chirlaque MD, Sánchez MJ, Palli D,
Kühn T, Murphy N, Cross AJ, Burnett-Hartman AN,
Chanock SJ, Chapelle A, Easton DF, Elliott F,
English DR, Feskens EJ, FitzGerald LM, Goodman PJ,
Hopper JL, Hudson TJ, Hunter DJ, Jacobs EJ, Joshu
CE, Küry S, Markowitz SD, Milne RL, Platz EA,
Rennert G, Rennert HS, Schumacher FR, Sandler RS,
Seminara D, Tangen CM, Thibodeau SN, Toland AE,
van Duijnhoven FJ, Visvanathan K, Vodickova L,
Potter JD, Männistö S, Weigl K, Figueiredo J,
Martín V, Larsson SC, Parfrey PS, Huang WY, Lenz
HJ, Castelao JE, Gago-Dominguez M, Muñoz-Garzón V,
Mancao C, Haiman CA, Wilkens LR, Siegel E, Barry
E, Younghusband B, Van Guelpen B, Harlid S,
Zeleniuch-Jacquotte A, Liang PS, Du M, Casey G,
Lindor NM, Le Marchand L, Gallinger SJ, Jenkins
MA, Newcomb PA, Gruber SB, Schoen RE, Hampel H,
Corley DA, Hsu L, Peters U, Hayes RB. Cumulative
Burden of Colorectal Cancer-Associated Genetic
Variants is More Strongly Associated With
Early-onset vs Late-onset Cancer. Gastroenterology
2020;158(5):1274-1286
168. Carr PR, Amitay EL, Jansen L, Alwers E, Roth
W, Herpel E, Kloor M, Schneider M, Bläker H,
Chang-Claude J, Brenner H, Hoffmeister M.
Association of BMI and major molecular
pathological markers of colorectal cancer in men
and women. Am J Clin Nutr 2020;111(3):562-569
167. McNabb S, Harrison TA, Albanes D, Berndt SI,
Brenner H, Caan BJ, Campbell PT, Cao Y,
Chang-Claude J, Chan A, Chen Z, English DR, Giles
GG, Giovannucci EL, Goodman PJ, Hayes RB,
Hoffmeister M, Jacobs EJ, Joshi AD, Larsson SC, Le
Marchand L, Li L, Lin Y, Männistö S, Milne RL, Nan
H, Newton C, Ogino S, Parfrey PS, Petersen PS,
Potter JD, Schoen RE, Slattery ML, Su YR, Tangen
CM, Tucker TC, Weinstein SJ, White E, Wolk A,
Woods MO, Phipps AI, Peters U. Meta-analysis of 16
studies of the association of alcohol with
colorectal cancer. Int J Cancer
2020;146(3):861-873
166. Beyerle J*, Holowatyj AN*, Haffa M, Frei E,
Gigic B, Schrotz-King P, Böhm J, Habermann N,
Stiborova M, Scherer D, Koelsch T, Skender S,
Becker N, Herpel E, Schneider M, Ulrich A,
Schirmacher P, Chang-Claude J, Brenner H,
Hoffmeister M, Haug U, Owen RW, Ulrich CM (*shared
authorship). Expression patterns of xenobiotic
metabolizing enzymes in tumor and adjacent normal
mucosa tissues among patients with colorectal
cancer: The ColoCare Study. Cancer Epidemiol
Biomark Prev 2020;29(2):460-469
165. Alwers E, Jansen L, Bläker H, Kloor M,
Tagscherer KE, Roth W, Boakye D, Herpel E,
Grüllich C, Chang-Claude J, Brenner H, Hoffmeister
M. Microsatellite instability and survival after
adjuvant chemotherapy among stage II and III colon
cancer patients: results from a population-based
study. Mol Oncol 2020;14(2):363-372
164. Pardini B, Corrado A, Paolicchi E, Cugliari
G, Berndt SI, Bezieau S, Bien SA, Brenner H, Caan
BJ, Campbell PT, Casey G, Chan AT, Chang-Claude J,
Cotterchio M, Gala M, Gallinger SJ, Haile RW,
Harrison TA, Hayes RB, Hoffmeister M, Hopper JL,
Hsu L, Huyghe J, Jenkins MA, Le Marchand L, Lin Y,
Lindor NM, Nan H, Newcomb PA, Ogino S, Potter JD,
Schoen RE, Slattery ML, White E, Vodickova L,
Vymetalkova V, Vodicka P, Gemignani F, Peters U,
Naccarati A, Landi S.. DNA repair and cancer in
colon and rectum: novel players in genetic
susceptibility. Int J Cancer 2020;146(2):363-372
163. Cornish AJ, Law PJ, Timofeeva M, Palin K,
Farrington SM, Palles C, Jenkins MA, Casey G,
Brenner H, Chang-Claude J, Hoffmeister M, Kirac I,
Maughan T, Brezina S, Gsur A, Cheadle JP, Aaltonen
LA, Tomlinson I, Dunlop MG, Houlston RS.
Modifiable pathways for colorectal cancer: a
Mendelian randomisation analysis. Lancet
Gastroenterol Hepatol 2020;5(1):55-62
162. Boakye D, Walter V, Jansen L, Martens UM,
Chang-Claude J, Hoffmeister M, Brenner H.
Magnitude of the age advancement effect of
comorbidities in colorectal cancer prognosis. J
Natl Compr Canc Netw 2020;18(1):59-68
161. Weigl K, Chang-Claude J, Hsu L, Hoffmeister
M, Brenner H. Establishing a valid approach for
estimating familial risk of cancer explained by
common genetic risk variants. Int J Cancer
2020;146(1):68-75
2019
160. Wang X, Dai JY, Albanes D, Arndt V, Berndt
SI, Bézieau S, Brenner H, Buchanan DD, Butterbach
K, Caan B, Casey G, Campbell PT, Chan AT, Chen Z,
Chang-Claude J, Cotterchio M, Easton DF, Giles GG,
Giovannucci E, Grady WM, Hoffmeister M, Hopper JL,
Hsu L, Jenkins MA, Joshi AD, Lampe JW, Larsson SC,
Lejbkowicz F, Li L, Lindblom A, Le Marchand L,
Martin V, Milne RL, Moreno V, Newcomb PA, Offitt
K, Ogino S, Pharoah PDP, Pinchev M, Potter JD,
Rennert HS, Rennert G, Saliba W, Schafmayer C,
Schoen RE, Schrotz-King P, Slattery ML, Song M,
Stegmaier C, Weinstein SJ, Wolk A, Woods MO, Wu
AH, Gruber SB, Peters U, White E. Mendelian
randomization analysis of C-reactive protein on
colorectal cancer risk. Int J Epidemiol
2019;48(3):767-780
159. Weigl K, Hsu L, Knebel P, Hoffmeister M,
Timofeeva M, Farrington S, Dunlop M, Brenner H.
Head-to-Head Comparison of Family History of
Colorectal Cancer and a Genetic Risk Score for
Colorectal Cancer Risk Stratification. Clin Transl
Gastroenterol 2019;10(12):e00106
158. Neumeyer S, Popanda O, Butterbach K, Edelmann
D, Bläker H, Toth C, Roth W, Herpel E, Jäkel C,
Schmezer P, Benner A, Burwinkel B, Hoffmeister M,
Brenner H, Chang-Claude J. DNA methylation
profiling to explore colorectal tumor differences
according to menopausal hormone therapy use in
women. Epigenomics 2019;11(16):1765-1778
157. Wang X, O'Connell K, Jeon J, Song M, Hunter
D, Hoffmeister M, Lin Y, Berndt S, Brenner H, Chan
AT, Chang-Claude J, Gong J, Gunter MJ, Harrison
TA, Hayes RB, Joshi A, Newcomb P, Schoen R,
Slattery ML, Vargas A, Potter JD, Le Marchand L,
Giovannucci E, White E, Hsu L, Peters U, Du M.
Combined effect of modifiable and non-modifiable
risk factors for colorectal cancer risk in a
pooled analysis of 11 population-based studies.
BMJ Open Gastroenterol 2019;6(1):e000339
156. Boakye D, Jansen L, Schneider M, Chang-Claude
J, Hoffmeister M, Brenner H. Personalizing the
prediction of colorectal cancer prognosis by
incorporating comorbidities and functional status
into prognostic nomograms. Cancers 2019;11(10):
E1435
155. Boakye D, Walter V, Martens UM, Chang-Claude
J, Hoffmeister M, Jansen L, Brenner H. Treatment
selection bias for chemotherapy persists in
colorectal cancer patient cohort studies even in
comprehensive propensity score analyses. Clin
Epidemiol 2019;11:821-32
154. Walter V, Boakye D, Weberpals J, Jansen L,
Haefeli WE, Martens UM, Knebel, P,
Chang-Claude J, Hoffmeister M, Brenner H.
Decreasing use of chemotherapy in older patients
with stage III colon cancer patients irrespective
of comorbidities. J Natl Compr Canc Netw
2019;17(9):1089-99
153. Geijsen AJMR, Brezina S, Keski-Rahkonen P,
Baierl A, Bachleitner-Hofmann T, Bergmann MM,
Boehm J, Brenner H, Chang-Claude J, van Duijnhoven
FJB, Gigic B, Gumpenberger T, Hofer P, Hoffmeister
M, Holowatyj AN, Karner-Hanusch J, Kok DE, Leeb G,
Ulvik A, Robinot N, Ose J, Stift A, Schrotz-King
P, Ulrich AB, Ueland PM, Kampman E, Scalbert A,
Habermann N, Gsur A, Ulrich CM. Plasma metabolites
associated with colorectal cancer: A
discovery-replication strategy. Int J Cancer
2019;145(5):1222-31
152. Zaimenko I, Jaeger C, Brenner H, Chang-Claude
J, Hoffmeister M, Grötzinger C, Detjen K, Burock
S, Schmitt CA, Stein U, Lisec J. Non-invasive
metastasis prognosis from plasma metabolites in
stage II colorectal cancer patients: the DACHS
study. Int J Cancer 2019;145(1):221-31
151. Alwers E, Bläker H, Walter V, Jansen L, Kloor
M, Arnold A, Sieber-Frank J, Herpel E, Tagscherer
KE, Roth W, Chang-Claude J, Brenner H, Hoffmeister
M. External validation of molecular subtype
classifications of colorectal cancer based on
microsatellite instability, CIMP, BRAF and KRAS.
BMC Cancer 2019;19(1):681
150. Jia M, Jansen L, Walter V, Edelmann D,
Maierthaler M, Tagscherer KE, Roth W, Herpel E,
Kloor M, Ulrich A, Burwinkel B, Bläker H,
Chang-Claude J, Brenner H, Hoffmeister M. A
prognostic CpG score derived from epigenome-wide
profiling of tumor tissue was independently
associated with colorectal cancer survival. Clin
Epigenet 2019;11(1):109
149. Kather JN, Pearson AT, Halama N, Jäger D,
Krause J, Loosen SH, Marx A, Boor P, Tacke F,
Neumann UP, Grabsch HI, Yoshikawa T, Brenner H,
Chang-Claude J, Hoffmeister M, Trautwein C, Luedde
T. Deep learning can predict microsatellite
instability directly from histology in
gastrointestinal cancer. Nature Med
2019;25(7):1054-56
148. Carr PR, Hoffmeister M. Leserbrief zum
Beitrag: „Gesunde Lebensführung reduziert
KRK-Risiko“ [Letter in German]. Z Gastroenterol
2019;57(6):784
147. Carr PR, Banbury B, Berndt SI, Campbell PT,
Chang-Claude J, Hayes RB, Howard BV, Jansen L,
Jacobs E, Lane DS, Nishihara R, Ogino S, Phipps
AI, Slattery ML, Stefanick ML, Wallace R, Walter
V, White E, Wu K, Peters U, Chan AT, Newcomb PA,
Brenner H, Hoffmeister M. Association Between
Intake of Red and Processed Meat and Survival in
Patients With Colorectal Cancer in a Pooled
Analysis. Clin Gastroenterol Hep
2019;17(8):1561-70
146. Chen C, Stock C, Jansen L, Chang-Claude J,
Hoffmeister M, Brenner H. Trends in colonoscopy
and fecal occult blood test use after the
introduction of dual screening offers in Germany:
results from a large population-based study,
2003-2016. Prev Med 2019;123:333-340
145. Law PJ, Timofeeva M, Fernandez-Rozadilla C,
Broderick P, Studd J, Fernandez-Tajes J,
Farrington S, Svinti V, Palles C, Orlando G, Sud
A, Holroyd A, Penegar S, Theodoratou E,
Vaughan-Shaw P, Campbell H, Zgaga L, Hayward C,
Campbell A, Harris S, Deary IJ, Starr J, Gatcombe
L, Pinna M, Briggs S, Martin L, Jaeger E,
Sharma-Oates A, East J, Leedham S, Arnold R,
Johnstone E, Wang H, Kerr D, Kerr R, Maughan T,
Kaplan R, Al-Tassan N, Palin K, Hänninen UA,
Cajuso T, Tanskanen T, Kondelin J, Kaasinen E,
Sarin AP, Eriksson JG, Rissanen H, Knekt P,
Pukkala E, Jousilahti P, Salomaa V, Ripatti S,
Palotie A, Renkonen-Sinisalo L, Lepistö A, Böhm J,
Mecklin JP, Buchanan DD, Win AK, Hopper J, Jenkins
ME, Lindor NM, Newcomb PA, Gallinger S, Duggan D,
Casey G, Hoffmann P, Nöthen MM, Jöckel KH, Easton
DF, Pharoah PDP, Peto J, Canzian F, Swerdlow A,
Eeles RA, Kote-Jarai Z, Muir K, Pashayan N;
PRACTICAL consortium, Harkin A, Allan K, McQueen
J, Paul J, Iveson T, Saunders M, Butterbach K,
Chang-Claude J, Hoffmeister M, Brenner H, Kirac I,
Matošević P, Hofer P, Brezina S, Gsur A, Cheadle
JP, Aaltonen LA, Tomlinson I, Houlston RS, Dunlop
MG. Association analyses identify 31 new risk loci
for colorectal cancer susceptibility. Nat Comm
2019;10(1):2154
144. Neumeyer S, Popanda O, Edelmann D, Butterbach
K, Toth C, Roth W, Bläker H, Jiang R, Herpel E,
Jäkel C, Schmezer P, Jansen L, Alwers E, Benner A,
Burwinkel B, Hoffmeister M, Brenner H,
Chang-Claude J. Genome-wide DNA methylation
differences according to oestrogen receptor beta
status in colorectal cancer. Epigenetics
2019;14(5):477-93
143. Amitay EL, Carr PR, Jansen L, Walter V, Roth
W, Herpel E, Kloor M, Bläker H, Chang-Claude J,
Brenner H, Hoffmeister M. Association of aspirin
and non-steroidal anti-inflammatory drugs with
colorectal cancer risk by molecular subtypes. J
Natl Cancer Inst 2019;111(5):475-83
142. Bien SA, Su YR, Conti DV, Harrison TA, Qu C,
Guo X, Lu Y, Albanes D, Auer PL, Banbury BL,
Berndt SI, Bézieau S, Brenner H, Buchanan DD, Caan
BJ, Campbell PT, Carlson CS, Chan AT, Chang-Claude
J, Chen S, Connolly CM, Easton DF, Feskens EJM,
Gallinger S, Giles GG, Gunter MJ, Hampe J, Huyghe
JR, Hoffmeister M, Hudson TJ, Jacobs EJ, Jenkins
MA, Kampman E, Kang HM, Kühn T, Küry S, Lejbkowicz
F, Le Marchand L, Milne RL, Li L, Li CI, Lindblom
A, Lindor NM, Martín V, McNeil CE, Melas M, Moreno
V, Newcomb PA, Offit K, Pharaoh PDP, Potter JD, Qu
C, Riboli E, Rennert G, Sala N, Schafmayer C,
Scacheri PC, Schmit SL, Severi G, Slattery ML,
Smith JD, Trichopoulou A, Tumino R, Ulrich CM, van
Duijnhoven FJB, Van Guelpen B, Weinstein SJ, White
E, Wolk A, Woods MO, Wu AH, Abecasis GR, Casey G,
Nickerson DA, Gruber SB, Hsu L, Zheng W, Peters U.
Genetic variant predictors of gene expression
provide new insight into risk of colorectal
cancer. Hum Genet 2019;138(4):307-326
141. Lu Y, Kweon SS, Tanikawa C, Jia WH, Xiang YB,
Cai Q, Zeng C, Schmit SL, Shin A, Matsuo K, Jee
SH, Kim DH, Kim J, Wen W, Shi J, Guo X, Li B, Wang
N, Zhang B, Li X, Shin MH, Li HL, Ren Z, Oh JH,
Oze I, Ahn YO, Jung KJ, Conti DV, Schumacher FR,
Rennert G, Jenkins MA, Campbell PT, Hoffmeister M,
Casey G, Gruber SB, Gao J, Gao YT, Pan ZZ,
Kamatani Y, Zeng YX, Shu XO, Long J, Matsuda K,
Zheng W. Large-scale Genome-wide Association Study
of East Asians Identifies Loci Associated With
Risk for Colorectal Cancer. Gastroenterology
2019;156(5):1455-66
140. Jiang R, Poschet G, Owen R, Celik M, Jansen
L, Hell R, Hoffmeister M, Brenner H, Chang-Claude
J. Serum concentration of genistein, luteolin and
colorectal cancer prognosis. Nutrients
2019;11(3):600
139. Rahbari NN, Carr PR, Jansen L, Chang-Claude
J, Weitz J, Hoffmeister M, Brenner H. Time of
metastasis and outcome in colorectal cancer. Ann
Surg 2019;269(3):494-502
138. Schmit SL, Edlund CK, Schumacher FR, Gong J,
Harrison TA, Huyghe JR, Qu C, Melas M, Van Den
Berg DJ, Wang H, Tring S, Plummer SJ, Albanes D,
Alonso MH, Amos CI, Anton K, Aragaki AK, Arndt V,
Barry EL, Berndt SI, Bezieau S, Bien S, Bloomer A,
Boehm J, Boutron-Ruault MC, Brenner H, Brezina S,
Buchanan DD, Butterbach K, Caan BJ, Campbell PT,
Carlson CS, Castelao JE, Chan AT, Chang-Claude J,
Chanock SJ, Cheng I, Cheng YW, Chin LS, Church JM,
Church T, Coetzee GA, Cotterchio M, Cruz Correa M,
Curtis KR, Duggan D, Easton DF, English D, Feskens
EJM, Fischer R, FitzGerald LM, Fortini BK,
Fritsche LG, Fuchs CS, Gago-Dominguez M, Gala M,
Gallinger SJ, Gauderman WJ, Giles GG, Giovannucci
EL, Gogarten SM, Gonzalez-Villalpando C,
Gonzalez-Villalpando EM, Grady WM, Greenson JK,
Gsur A, Gunter M, Haiman CA, Hampe J, Harlid S,
Harju JF, Hayes RB, Hofer P, Hoffmeister M, Hopper
JL, Huang SC, Huerta JM, Hudson TJ, Hunter DJ,
Idos GE, Iwasaki M, Jackson RD, Jacobs EJ, Jee SH,
Jenkins MA, Jia WH, Jiao S, Joshi AD, Kolonel LN,
Kono S, Kooperberg C, Krogh V, Kuehn T, Küry S,
LaCroix A, Laurie CA, Lejbkowicz F, Lemire M, Lenz
HJ, Levine D, Li CI, Li L, Lieb W, Lin Y, Lindor
NM, Liu YR, Loupakis F, Lu Y, Luh F, Ma J, Mancao
C, Manion FJ, Markowitz SD, Martin V, Matsuda K,
Matsuo K, McDonnell KJ, McNeil CE, Milne R, Molina
AJ, Mukherjee B, Murphy N, Newcomb PA, Offit K,
Omichessan H, Palli D, Cotoré JPP, Pérez-Mayoral
J, Pharoah PD, Potter JD, Qu C, Raskin L, Rennert
G, Rennert HS, Riggs BM, Schafmayer C, Schoen RE,
Sellers TA, Seminara D, Severi G, Shi W, Shibata
D, Shu XO, Siegel EM, Slattery ML, Southey M,
Stadler ZK, Stern MC, Stintzing S, Taverna D,
Thibodeau SN, Thomas DC, Trichopoulou A, Tsugane
S, Ulrich CM, van Duijnhoven FJB, van Guelpan B,
Vijai J, Virtamo J, Weinstein SJ, White E, Win AK,
Wolk A, Woods M, Wu AH, Wu K, Xiang YB, Yen Y,
Zanke BW, Zeng YX, Zhang B, Zubair N, Kweon SS,
Figueiredo JC, Zheng W, Marchand LL, Lindblom A,
Moreno V, Peters U, Casey G, Hsu L, Conti DV,
Gruber SB. Novel common genetic susceptibility
loci for colorectal cancer. J Natl Cancer Inst
2019;111(2):146-57
137. Bläker H*, Alwers E*, Arnold A, Herpel E,
Roth W, Jansen J, Walter V, Kloor M, Chang-Claude
J, Brenner H, Hoffmeister M (*shared first
authorship). The association of BRAF mutations
with adverse outcome in colorectal cancers depends
on the microsatellite status and tumor stage. Clin
Gastroenterol Hepatol 2019;17(3):455-62
136. Huyghe JR, Bien SA, Harrison TA, Kang HM,
Chen S, Schmit SL, Conti DV, Qu C, Jeon J, Edlund
CK, Greenside P, Wainberg M, Schumacher FR, Smith
JD, Levine DM, Nelson SC, Sinnott-Armstrong NA,
Albanes D, Alonso MH, Anderson K, Arnau-Collell C,
Arndt V, Bamia C, Banbury BL, Baron JA, Berndt SI,
Bézieau S, Bishop DT, Boehm J, Boeing H, Brenner
H, Brezina S, Buch S, Buchanan DD, Burnett-Hartman
A, Butterbach K, Caan BJ, Campbell PT, Carlson CS,
Castellví-Bel S, Chan AT, Chang-Claude J, Chanock
SJ, Chirlaque MD, Cho SH, Connolly CM, Cross AJ,
Cuk K, Curtis KR, de la Chapelle A, Doheny KF,
Duggan D, Easton DF, Elias SG, Elliott F, English
DR, Feskens EJM, Figueiredo JC, Fischer R,
FitzGerald LM, Forman D, Gala M, Gallinger S,
Gauderman WJ, Giles GG, Gillanders E, Gong J,
Goodman PJ, Grady WM, Grove JS, Gsur A, Gunter MJ,
Haile RW, Hampe J, Hampel H, Harlid S, Hayes RB,
Hofer P, Hoffmeister M, Hopper JL, Hsu WL, Huang
WY, Hudson TJ, Hunter DJ, Ibañez-Sanz G, Idos GE,
Ingersoll R, Jackson RD, Jacobs EJ, Jenkins MA,
Joshi AD, Joshu CE, Keku TO, Key TJ, Kim HR,
Kobayashi E, Kolonel LN, Kooperberg C, Kühn T,
Küry S, Kweon SS, Larsson SC, Laurie CA, Le
Marchand L, Leal SM, Lee SC, Lejbkowicz F, Lemire
M, Li CI, Li L, Lieb W, Lin Y, Lindblom A, Lindor
NM, Ling H, Louie TL, Männistö S, Markowitz SD,
Martín V, Masala G, McNeil CE, Melas M, Milne RL,
Moreno L, Murphy N, Myte R, Naccarati A, Newcomb
PA, Offit K, Ogino S, Onland-Moret NC, Pardini B,
Parfrey PS, Pearlman R, Perduca V, Pharoah PDP,
Pinchev M, Platz EA, Prentice RL, Pugh E, Raskin
L, Rennert G, Rennert HS, Riboli E,
Rodríguez-Barranco M, Romm J, Sakoda LC,
Schafmayer C, Schoen RE, Seminara D, Shah M,
Shelford T, Shin MH, Shulman K, Sieri S, Slattery
ML, Southey MC, Stadler ZK, Stegmaier C, Su YR,
Tangen CM, Thibodeau SN, Thomas DC, Thomas SS,
Toland AE, Trichopoulou A, Ulrich CM, Van Den Berg
DJ, van Duijnhoven FJB, Van Guelpen B, van Kranen
H, Vijai J, Visvanathan K, Vodicka P, Vodickova L,
Vymetalkova V, Weigl K, Weinstein SJ, White E, Win
AK, Wolf CR, Wolk A, Woods MO, Wu AH, Zaidi SH,
Zanke BW, Zhang Q, Zheng W, Scacheri PC, Potter
JD, Bassik MC, Kundaje A, Casey G, Moreno V,
Abecasis GR, Nickerson DA, Gruber SB, Hsu L,
Peters U. Discovery of common and rare genetic
risk variants for colorectal cancer. Nat Genet
2019;51(1):76-87
135. Jiang X, Finucane HK, Schumacher FR, Schmit
SL, Tyrer JP, Han Y, Michailidou K, Lesseur C,
Kuchenbaecker KB, Dennis J, Conti DV, Casey G,
Gaudet MM, Huyghe JR, Albanes D, Aldrich MC,
Andrew AS, Andrulis IL, Anton-Culver H, Antoniou
AC, Antonenkova NN, Arnold SM, Aronson KJ, Arun
BK, Bandera EV, Barkardottir RB, Barnes DR, Batra
J, Beckmann MW, Benitez J, Benlloch S, Berchuck A,
Berndt SI, Bickeböller H, Bien SA, Blomqvist C,
Boccia S, Bogdanova NV, Bojesen SE, Bolla MK,
Brauch H, Brenner H, Brenton JD, Brook MN, Brunet
J, Brunnström H, Buchanan DD, Burwinkel B, Butzow
R, Cadoni G, Caldés T, Caligo MA, Campbell I,
Campbell PT, Cancel-Tassin G, Cannon-Albright L,
Campa D, Caporaso N, Carvalho AL, Chan AT,
Chang-Claude J, Chanock SJ, Chen C, Christiani DC,
Claes KBM, Claessens F, Clements J, Collée JM,
Correa MC, Couch FJ, Cox A, Cunningham JM,
Cybulski C, Czene K, Daly MB, deFazio A, Devilee
P, Diez O, Gago-Dominguez M, Donovan JL, Dörk T,
Duell EJ, Dunning AM, Dwek M, Eccles DM, Edlund
CK, Edwards DRV, Ellberg C, Evans DG, Fasching PA,
Ferris RL, Liloglou T, Figueiredo JC, Fletcher O,
Fortner RT, Fostira F, Franceschi S, Friedman E,
Gallinger SJ, Ganz PA, Garber J, García-Sáenz JA,
Gayther SA, Giles GG, Godwin AK, Goldberg MS,
Goldgar DE, Goode EL, Goodman MT, Goodman G,
Grankvist K, Greene MH, Gronberg H, Gronwald J,
Guénel P, Håkansson N, Hall P, Hamann U, Hamdy FC,
Hamilton RJ, Hampe J, Haugen A, Heitz F, Herrero
R, Hillemanns P, Hoffmeister M, Høgdall E, Hong
YC, Hopper JL, Houlston R, Hulick PJ, Hunter DJ,
Huntsman DG, Idos G, Imyanitov EN, Ingles SA,
Isaacs C, Jakubowska A, James P, Jenkins MA,
Johansson M, Johansson M, John EM, Joshi AD,
Kaneva R, Karlan BY, Kelemen LE, Kühl T, Khaw KT,
Khusnutdinova E, Kibel AS, Kiemeney LA, Kim J,
Kjaer SK, Knight JA, Kogevinas M, Kote-Jarai Z,
Koutros S, Kristensen VN, Kupryjanczyk J, Lacko M,
Lam S, Lambrechts D, Landi MT, Lazarus P, Le ND,
Lee E, Lejbkowicz F, Lenz HJ, Leslie G, Lessel D,
Lester J, Levine DA, Li L, Li CI, Lindblom A,
Lindor NM, Liu G, Loupakis F, Lubiński J, Maehle
L, Maier C, Mannermaa A, Marchand LL, Margolin S,
May T, McGuffog L, Meindl A, Middha P, Miller A,
Milne RL, MacInnis RJ, Modugno F, Montagna M,
Moreno V, Moysich KB, Mucci L, Muir K, Mulligan
AM, Nathanson KL, Neal DE, Ness AR, Neuhausen SL,
Nevanlinna H, Newcomb PA, Newcomb LF, Nielsen FC,
Nikitina-Zake L, Nordestgaard BG, Nussbaum RL,
Offit K, Olah E, Olama AAA, Olopade OI, Olshan AF,
Olsson H, Osorio A, Pandha H, Park JY, Pashayan N,
Parsons MT, Pejovic T, Penney KL, Peters WHM,
Phelan CM, Phipps AI, Plaseska-Karanfilska D,
Pring M, Prokofyeva D, Radice P, Stefansson K,
Ramus SJ, Raskin L, Rennert G, Rennert HS, van
Rensburg EJ, Riggan MJ, Risch HA, Risch A, Roobol
MJ, Rosenstein BS, Rossing MA, De Ruyck K,
Saloustros E, Sandler DP, Sawyer EJ, Schabath MB,
Schleutker J, Schmidt MK, Setiawan VW, Shen H,
Siegel EM, Sieh W, Singer CF, Slattery ML,
Sorensen KD, Southey MC, Spurdle AB, Stanford JL,
Stevens VL, Stintzing S, Stone J, Sundfeldt K,
Sutphen R, Swerdlow AJ, Tajara EH, Tangen CM,
Tardon A, Taylor JA, Teare MD, Teixeira MR, Terry
MB, Terry KL, Thibodeau SN, Thomassen M, Bjørge L,
Tischkowitz M, Toland AE, Torres D, Townsend PA,
Travis RC, Tung N, Tworoger SS, Ulrich CM, Usmani
N, Vachon CM, Van Nieuwenhuysen E, Vega A,
Aguado-Barrera ME, Wang Q, Webb PM, Weinberg CR,
Weinstein S, Weissler MC, Weitzel JN, West CML,
White E, Whittemore AS, Wichmann HE, Wiklund F,
Winqvist R, Wolk A, Woll P, Woods M, Wu AH, Wu X,
Yannoukakos D, Zheng W, Zienolddiny S, Ziogas A,
Zorn KK, Lane JM, Saxena R, Thomas D, Hung RJ,
Diergaarde B, McKay J, Peters U, Hsu L,
García-Closas M, Eeles RA, Chenevix-Trench G,
Brennan PJ, Haiman CA, Simard J, Easton DF, Gruber
SB, Pharoah PDP, Price AL, Pasaniuc B, Amos CI,
Kraft P, Lindström S. Shared heritability and
functional enrichment across six solid cancers.
Nat Comm 2019;10(1):431
134. Gündert M, Edelmann D, Benner A, Jansen L,
Jia M, Walter V, Knebel P, Herpel E, Chang-Claude
J, Hoffmeister M, Brenner H, Burwinkel B.
Genome-wide methylation analysis reveals a
prognostic classifier for non-metastatic
colorectal cancer (ProMCol classifier). Gut
2019;68(1):101-10
133. Kather JN, Krisam J, Charoentong P, Luedde T,
Herpel E, Weis CA, Gaiser T, Marx A, Valous NA,
Ferber D, Jansen L, Reyes-Aldasoro CC, Zörnig I,
Jäger D, Brenner H, Chang-Claude J, Hoffmeister M,
Halama N. Predicting survival from colorectal
cancer histology slides using deep learning: a
retrospective multicenter study. PLOS Med
2019;16(1):e1002730
2018
132. Carr PR, Weigl K,
Jansen L, Walter V, Erben V, Chang-Claude J,
Brenner H, Hoffmeister M. Healthy lifestyle
factors associated with lower risk of colorectal
cancer irrespective of genetic risk.
Gastroenterology 2018;155(6):1805-15
131. Eyl RE, Koch-Gallenkamp L, Jansen L, Walter
V, Carr P, Hoffmeister M, Chang-Claude J, Brenner
H, Arndt V. Potential determinants of physical
inactivity among long-term colorectal cancer
survivors. J Cancer Surviv 2018;12(5):679-90
130. Kather JN, Suarez-Carmona M, Charoentong P,
Weis CA, Hirsch D, Bankhead P, Horning M, Ferber
D, Kel I, Herpel E, Schott S, Zörnig I, Utikal J,
Marx A, Gaiser T, Brenner H, Chang-Claude J,
Hoffmeister M, Jäger D, Halama N. Topography of
cancer-associated immune cells in human solid
tumors. Elife 2018 Sep 4;7
129. Wang X, Chan AT, Slattery ML, Chang-Claude J,
Potter JD, Gallinger S, Caan B, Lampe JW, Newcomb
PA, Zubair N, Hsu L, Schoen RE, Hoffmeister M,
Brenner H, Le Marchand L, Peters U, White E.
Influence of smoking, body mass index and other
factors on the preventive effect of nonsteroidal
anti-inflammatory drugs on colorectal cancer risk.
Cancer Res 2018;78(16):4790-99
128. Jeon J, Du M, Schoen RE, Hoffmeister M,
Newcomb PA, Berndt SI, Caan B, Campbell PT, Chan
AT, Chang-Claude J, Giles GG, Gong J, Harrison TA,
Huyghe JR, Jacobs EJ, Li L, Lin Y, Le Marchand L,
Potter JD, Qu F, Bien SA, Zubair N, Macinnis RJ,
Buchanan DD, Hopper JL, Cao Y, Nishihara R,
Rennert G, Slattery ML, Thomas DC, Woods MO,
Prentice RL, Gruber SB, Zheng Y, Brenner H, Hayes
RB, White E, Peters U, Hsu L; Colorectal
Transdisciplinary (CORECT) Study and Genetics and
Epidemiology of Colorectal Cancer Consortium
(GECCO). Determining Risk of Colorectal Cancer and
Starting Age of Screening Based on Lifestyle,
Environmental, and Genetic Factors.
Gastroenterology 2018;154(8):2152-64
127. Huhn S, da Silva Filho MI, Sanmuganantham T,
Pichulik T, Catalano C, Pardini B, Naccarati A,
Polakova-Vymetálkova V, Jiraskova K, Vodickova L,
Vodicka P, Löffler MW, Courth L, Wehkamp J, Din
FVN, Timofeeva M, Farrington SM, Jansen L,
Hemminki K, Chang-Claude J, Brenner H, Hoffmeister
M, Dunlop MG, Weber ANR, Försti A. Coding variants
in NOD-like receptors: an association study on
risk and survival of colorectal cancer. PLOS One
2018;13(6):e0199350
126. Su YR, Di C, Bien S, Huang L, Dong X,
Abecasis G, Berndt S, Bezieau S, Brenner H, Caan
B, Casey G, Chang-Claude J, Chanock S, Chen S,
Connolly C, Curtis K, Figueiredo J, Gala M,
Gallinger S, Harrison T, Hoffmeister M, Hopper J,
Huyghe JR, Jenkins M, Joshi A, Le Marchand L,
Newcomb P, Nickerson D, Potter J, Schoen R,
Slattery M, White E, Zanke B, Peters U, Hsu L. A
Mixed-Effects Model for Powerful Association Tests
in Integrative Functional Genomics. Am J Hum Genet
2018, in press
125. Neumeyer S, Banbury BL, Arndt V, Berndt SI,
Bezieau S, Bien SA, Buchanan DD, Butterbach K,
Caan BJ, Campbell PT, Casey G, Chan AT, Chanock
SJ, Dai JY, Gallinger S, Giovannucci EL, Giles GG,
Grady WM, Hampe J, Hoffmeister M, Hopper JL, Hsu
L, Jenkins MA, Joshi A, Larsson SC, Le Marchand L,
Lindblom A, Moreno V, Lemire M, Li L, Lin Y, Offit
K, Newcomb PA, Pharaoh PD, Potter JD, Qi L,
Rennert G, Schafmayer C, Schoen RE, Slattery ML,
Song M, Ulrich CM, Win AK, White E, Wolk A, Woods
MO, Wu AH, Gruber SB, Brenner H, Peters U,
Chang-Claude J. Mendelian Randomization study of
age at menarche and age at menopause and the risk
of colorectal cancer. Br J Cancer
2018;118(12):1639-47
124. Maalmi H, Walter W, Jansen L, Owen RW, Ulrich
A, Schöttker B, Chang-Claude J, Hoffmeister M,
Brenner H. Dose-Response Relationship between
Serum Retinol Levels and Survival in Patients with
Colorectal Cancer: Results from the DACHS Study.
Nutrients 2018; 10(4):510
123. Gigic B, Boeing H, Toth R, Böhm J, Habermann
N, Scherer D, Schrotz-King P, Abbenhardt-Martin C,
Skender S, Brenner H, Chang-Claude J, Hoffmeister
M, Syrjala K, Jacobsen PB, SchneiderM, Ulrich A,
Ulrich CM. Associations between dietary patterns
and longitudinal quality of life changes in
colorectal cancer patients: the ColoCare study.
Nutr Cancer 2018;70(1):51-60
122. Weigl K, Chang-Claude J, Knebel P, Hsu L,
Hoffmeister M, Brenner H. Strongly enhanced
colorectal cancer risk stratification by combining
family history and genetic risk score. Clin
Epidemiol 2018;10:143—152
2017
121. Maalmi H, Walter V, Jansen L, Chang-Claude J,
Owen R, Ulrich A,
Schöttker B, Hoffmeister M, Brenner H.
Relationship of very low serum
25-hydroxyvitamin D3 levels with long-term
survival in a large cohort
of colorectal cancer patients from Germany. Eur J
Epidemiol
2017;32(11):961-71
120. Bien SA, Auer P, Harrison TA, Qu C, Connolly
CM, Greenside
PG, Chen S, Berndt SI, Bézieau S, Kang HM, Huyghe
J, Brenner H, Casey
G, Chan AT, Hopper JL, Banbury BL, Chang-Claude J,
Chanock SJ, Haile
RW, Hoffmeister M, Fuchsberger C, Jenkins MA, Leal
SM, Lemire M,
Newcomb PA, Gallinger S, Potter JD, Schoen RE,
Slattery ML, Smith JD,
Le Marchand L, White E, Zanke BW, Abeçasis GR,
Carlson CS, Peters U,
Nickerson DA, Kundaje A, Hsu L. Enrichment of
colorectal cancer
associations in functional regions: insight for
using epigenomics data
in the analysis of whole genome sequence-imputed
GWAS data. PLOS One
2017;12(11):e0186518
119. Gu F, Zhang H, Hyland PL, Berndt S, Gapstur
SM, Wheeler W, Ellipse
Consortium T, Amos CI, Bezieau S, Bickeböller H,
Brenner H, Brennan P,
Chang-Claude J, Conti DV, Doherty JA, Gruber SB,
Harrison TA, Hayes RB,
Hoffmeister M, Houlston RS, Hung RJ, Jenkins MA,
Kraft P, Lawrenson K,
McKay J, Markt S, Mucci L, Phelan CM, Qu C, Risch
A, Rossing MA,
Wichmann HE, Shi J, Schernhammer E, Yu K, Landi
MT, Caporaso NE.
Inherited variation in circadian rhythm genes and
risks of prostate
cancer and three other cancer sites in combined
cancer consortia. Int J
Cancer 2017;141(9):1794-1802
118. Dimitrakopoulou VI*, Tsilidis KK*, Haycock
PC, Dimou NL,
Al-Dabhani K, Martin RM, Lewis SJ, Gunter MJ,
Mondul A, Shui IM,
Theodoratou E, Nimptsch K, Lindström S, Albanes D,
Kühn T, Key TJ,
Travis RC, Raskin L, Chan AT, Song M, Joshi AD,
Xiang YB, Jee SH,
Ulrich CM, Baron JA, Giles GG, MacInnis RJ,
Southey MC, Figueiredo JC,
Li L, Haiman CA, Landi MT, Stevens V, Caporaso N,
Brennan P, Amos CI,
Wu X, Hung RJ, Bickeböller H, Risch A, Wichmann
HE, Houlston R, Banbury
BL, Berndt SI, Bezieau S, Brenner H, Campbell PT,
Casey G, Chang-Claude
J, Gallinger SJ, Hoffmeister M, Jenkins MA, Le
Marchand L, Newcomb PA,
Peters U, Slattery ML, White E, Santhanakrishnan
Vimaleswaran K, Ahsan
H, Kraft P, Pierce BL, Schildkraut JM, on behalf
of GECCO, PRACTICAL
and the GAME-ON Network: CORECT, DRIVE, ELLIPSE,
FOCI-OCAC and
TRICL-ILCCO (*shared first authorship).
Circulating vitamin D
concentration and risk of seven cancers: a
Mendelian randomization
study. BMJ 2017;359:j4761
117. Gorfine M, Berndt SI, Chang-Claude J,
Hoffmeister M, Le Marchand
L, Potter J, Slattery ML, Keret N, Peters U, Hsu
L. Heritability
Estimation using a Regularized Regression Approach
(HERRA): Applicable
to Continuous, Dichotomous or Age-at-Onset
Outcome. PLOS One
2017;12(8):e0181269
116. Carr PR, Jansen L, Bienert S, Roth W, Herpel
E, Kloor M, Bläker H,
Chang-Claude J, Brenner H, Hoffmeister M.
Associations of red and
processed meat intake with major molecular
pathological features of
colorectal cancer. Eur J Epidemiol
2017;32(5):409-418
115. Rahbari NN, Carr PR, Jansen L, Chang-Claude
J, Weitz J,
Hoffmeister M, Brenner H. Time of metastasis and
outcome in colorectal
cancer. Ann Surg 2017 [Epub ahead of print]
114. Gündert M, Edelmann D, Benner A, Jansen L,
Jia M, Walter V, Knebel
P, Herpel E, Chang-Claude J, Hoffmeister M,
Brenner H, Burwinkel B.
Genome-wide methylation analysis reveals a
prognostic classifier for
non-metastatic colorectal cancer (ProMCol
classifier). Gut 2017 [Epub
ahead of print]
113.
Arnold A, Kloor M, Jansen L, Chang-Claude J,
Brenner H, von Winterfeld
M, Hoffmeister M, Bläker H. The
association between microsatellite
instability and lymph node count in colorectal
cancer. Virchows Arch
2017;471(1):57-64
112. Wieland E, Rodriguez-Vita J,
Liebler SS, Mogler C, Moll I, Herberich SE,
Espinet E, Herpel E,
Menuchin A, Chang-Claude J, Hoffmeister M,
Gebhardt C, Brenner H,
Trumpp A, Siebel CW, Hecker M, Utikal J, Sprinzak
D, Fischer A.
Endothelial
Notch1 activity facilitates metastasis.
Cancer Cell
2017;31(3):355-67
111. Walter V, Jansen L, Knebel P,
Chang-Claude J, Hoffmeister M, Brenner H. Physical
activity and
survival of colorectal cancer patients:
Population-based study from
Germany. Int J Cancer 2017;140(9):1985-97
110. Skender S, Böhm
J, Schrotz-King P, Chang-Claude J, Siegel EM,
Steindorf K, Owen RW, Ose
J, Hoffmeister M, Brenner H, Ulrich CM. Plasma
25-hydroxyvitamin D3
levels in colorectal cancer patients and
associations with physical
activity. Nutr Cancer 2017;69(2):229-37
109. Maierthaler M,
Benner A, Hoffmeister M, Surowy H, Jansen L,
Knebel P, Chang-Claude J,
Brenner H, Burwinkel B. Plasma
miR-122 and miR-200 family are
prognostic markers in colorectal cancer. Int
J Cancer
2017;140(1):176-187
2016
108. Jia M, Jansen J, Walter V, Tagscherer K,
Roth W, Herpel E, Kloor M, Bläker H, Chang-Claude
J, Brenner H,
Hoffmeister M. No
association of CpG island methylator phenotype
and
colorectal cancer survival: population-based
study. Br J Cancer
2016;115(11):1359-66
107. Walter V, Jansen L, Hoffmeister M, Ulrich A,
Roth W, Bläker H,
Chang-Claude J, Brenner H. Prognostic
relevance of prediagnostic weight
loss and overweight at diagnosis in patients
with colorectal cancer. Am
J Clin Nutr 2016;104(4):1110-1120
106. Weigl K, Jansen L, Chang-Claude J,
Knebel P, Hoffmeister M, Brenner H. Family
history
and the risk of
colorectal cancer: the importance of patients’
history of colonoscopy.
Int J Cancer 2016;139(19):2213-20
105. Yang B, Thrift AP,
Figueiredo JC, Jenkins MA, Schumacher FR, Conti
DV, Lin Y, Win AK,
Limburg PJ, Berndt SI, Brenner H, Chan AT,
Chang-Claude J, Hoffmeister
M, Hudson TJ, Marchand LL, Newcomb PA, Slattery
ML, White E, Peters U,
Casey G, Campbell PT. Common
variants
in the obesity-associated genes
FTO and MC4R are not associated with risk of
colorectal cancer.
Cancer
Epidemiol 2016;44:1-4
104. Du M, Jiao S, Bien SA,
Gala M, Abecasis G, Bezieau S, Brenner H,
Butterbach K, Caan BJ,
Carlson CS, Casey G, Chang-Claude J, Conti DV,
Curtis KR, Duggan D,
Gallinger S, Haile RW, Harrison TA, Hayes RB,
Hoffmeister M, Hopper JL,
Hudson TJ, Jenkins MA, Küry S, Le Marchand L, Leal
SM, Newcomb PA,
Nickerson DA, Potter JD, Schoen RE, Schumacher FR,
Seminara D, Slattery
ML, Hsu L, Chan AT, White E, Berndt SI, Peters U.
Fine-mapping
of
common
genetic variants associated with colorectal
tumor risk
identified potential functional variants.
PLoS One
2016;11(7):e0157521
103.
Brenner H, Jansen L, Ulrich A, Chang-Claude J,
Hoffmeister M. Survival
of
patients with symptom- and screening-detected
colorectal cancer.
Oncotarget 2016;7(28):44695-704
102. Walter V, Jansen L,
Ulrich A, Roth W, Bläker H, Chang-Claude J,
Hoffmeister M, Brenner H.
Alcohol
consumption
and survival of colorectal cancer patients: a
population-based study from Germany. Am J
Clin Nutr
2016;103(6):1497-506
101.
Zeng C, Matsuda K, Jia WH, Chang J, Kweon SS,
Xiang YB, Shin A, Jee SH,
Kim DH, Zhang B, Cai Q, Guo X, Long J, Wang N,
Courtney R, Pan Z, Wu C,
Takahashi A, Shin MH, Matsuo K, Matsuda F, Gao YT,
Oh JH, Kim S, Jung
KJ, Ahn YO, Ren Z, Li HL, Wu J, Shi J, Wen W, Yang
G, Li B, Ji BT;
Genetics and Epidemiology of Colorectal Cancer
Consortium (GECCO),
Brenner H, Schoen RE, Küry S; Colorectal
Transdisciplinary (CORECT)
Study, Gruber SB, Schumacher FR, Stenzel SL; Colon
Cancer Family
Registry (CCFR), Casey G, Hopper JL, Jenkins MA,
Kim HR, Jeong JY, Park
JW, Tajima K, Cho SH, Kubo M, Shu XO, Lin D, Zeng
YX, Zheng W.
Identification
of
susceptibility loci and genes for colorectal
cancer
risk. Gastroenterology 2016;150(7):1633-45
100. Gdynia G, Sauer
SW, Kopitz J, Fuchs D, Duglova K, Ruppert T,
Miller M, Pahl J, Cerwenka
A, Enders M, Mairbäurl H, Kami?ski MM, Penzel R,
Zhang C, Fuller JC,
Wade RC, Benner A, Chang-Claude J, Brenner H,
Hoffmeister M, Zentgraf
H, Schirmacher P, Roth W. The
HMGB1
protein induces a metabolic type of
tumor cell death by blocking aerobic respiration.
Nat Comm
2016;7:10764
99.
Kap EJ, Seibold P, Scherer D, Habermann N,
Balavarca Y, Jansen L,
Zucknick M, Becker N, Hoffmeister M, Ulrich A,
Benner A, Ulrich CM,
Burwinkel B, Brenner H, Chang-Claude J. SNPs
in
transporter and
metabolizing genes as predictive markers for
oxaliplatin treatment in
colorectal cancer patients. Int J Cancer
2016;138(12):2993-3001
98.
Garcia-Albeniz X, Rudolph A, Hutter C, White E,
Lin Y, Rosse SA,
Figueiredo JC, Harrison TA, Jiao S, Brenner H,
Casey G, Hudson TJ,
Thornquist M, Le Marchand L, Potter J, Slattery
ML, Zanke B, Baron JA,
Caan BJ, Chanock SJ, Berndt SI, Stelling D, Fuchs
CS, Hoffmeister M,
Butterbach K, Du M, James Gauderman W, Gunter MJ,
Lemire M, Ogino S,
Lin J, Hayes RB, Haile RW, Schoen RE, Warnick GS,
Jenkins MA, Thibodeau
SN, Schumacher FR, Lindor NM, Kolonel LN, Hopper
JL, Gong J, Seminara
D, Pflugeisen BM, Ulrich CM, Qu C, Duggan D,
Cotterchio M, Campbell PT,
Carlson CS, Newcomb PA, Giovannucci E, Hsu L, Chan
AT, Peters U,
Chang-Claude J. CYP24A1
variant
modifies the association of oestrogen
plus progesteron therapy and colorectal cancer
risk. Br J
Cancer
2016;114(2):221-9
97. Carr PR, Jansen L, Walter V, Kloor M, Roth
W, Bläker H, Chang-Claude J, Brenner H,
Hoffmeister. Associations
of
red
and processed meat with survival after
colorectal cancer and
differences according to timing of dietary
assessment. Am J
Clin Nutr
2016;103(1):192-200
96. Phipps AI, Passarelli MN, Chan AT,
Harrison TA, Jeon J, Hutter CM, Berndt SI, Brenner
H, Caan BJ, Campbell
PT, Chang-Claude J, Chanock SJ, Cheadle JP, Curtis
KR, Duggan D, Fisher
D, Fuchs CS, Gala M, Giovannucci EL, Hayes RB,
Hoffmeister M, Hsu L,
Jacobs EJ, Jansen L, Kaplan R, Kap EJ, Maughan TS,
Potter JD, Schoen
RE, Seminara D, Slattery ML, West H, White E,
Peters U, Newcomb PA.
Common
genetic
variation and survival after colorectal cancer
ciagnosis: a genome-wide analysis.
Carcinogenesis
2016;37(1):87-95
2015
95.
Schumacher FR, Schmit SL, Jiao S, Edlund CK, Wang
H, Zhang B, Hsu L,
Huang SC, Fischer CP, Harju JF, Idos GE,
Lejbkowicz F, Manion FJ,
McDonnell K, McNeil CE, Melas M, Rennert HS, Shi
W, Thomas DC, Van Den
Berg DJ, Hutter CM, Aragaki AK, Butterbach K, Caan
BJ, Carlson CS,
Chanock SJ, Curtis KR, Fuchs CS, Gala M,
Giocannucci EL, Gogarten SM,
Hayes RB, Henderson B, Hunter DJ, Jackson RD,
Kolonel LN, Kooperberg C,
Kury S, LaCroix A, Laurie CC, Laurie CA, Lemire M,
Levine D, Ma J,
Makar KW, Qu C, Taverna D, Ulrich CM, Wu K, Kono
S, West DW, Berndt SI,
Bezieau S, Brenner H, Campbell PT, Chan AT,
Chang-Claude J, Coetzee GA,
Conti DV, Duggan D, Figueiredo JC, Fortini BK,
Gallinger SJ, Gauderman
WJ, Giles G, Green R, Haile R, Harrison TA,
Hoffmeister M, Hopper JL,
Hudson TJ, Jacobs E, Iwasaki M, Jee SH, Jenkins M,
Jia WH, Joshi A, Li
L, Lindor NM, Matsuo K, Moreno V, Mukherjee B,
Newcomb PA, Potter JD,
Raskin L, Rennert G, Rosse S, Severi G, Schoen RE,
Seminara D, Shu XO,
Slattery ML, Tsugane S, White E, Xiang YB, Zanke
BW, Zheng W, Le
Marchand L, Casey G, Gruber SB, Peters U. Genome-wide
association
study
of colorectal cancer identifies six new
susceptibility loci.
Nat Commun
2015;6:7138
94. Pfütze K, Benner A, Hoffmeister M, Jansen L,
Yang R, Bläker H, Herpel E, Ulrich A, Ulrich CM,
Chang-Claude J,
Brenner H, Burwinkel B. Methylation
status
at HYAL2 predicts overall
and progression-free survival of colon cancer
patients under 5-FU
chemotherapy. Genomics 2015;106(6):348-54
93. Lemire M, Qu C,
Loo LW, Zaidi SH, Wang H, Berndt SI, Bézieau S,
Brenner H, Campbell PT,
Chan AT, Chang-Claude J, Du M, Edlund CK,
Gallinger S, Haile RW,
Harrison TA, Hoffmeister M, Hopper JL, Hou L, Hsu
L, Jacobs EJ, Jenkins
MA, Jeon J, Küry S, Li L, Lindor NM, Newcomb PA,
Potter JD, Rennert G,
Rudolph A, Schoen RE, Schumacher FR, Seminara D,
Severi G, Slattery ML,
White E, Woods MO, Cotterchio M, Le Marchand L,
Casey G, Gruber SB,
Peters U, Hudson TJ. A
genome-wide association study for colorectal
cancer identifies a risk locus in 14q23.1.
Hum Genet
2015;134(11-12):1249-62
92. Khalili H, Gong J, Brenner H, Austin
TR, Hutter CM, Baba Y, Baron JA, Berndt SI,
Bézieau S, Caan B, Campbell
PT, Chang-Claude J, Chanock SJ, Chen C, Hsu L,
Jiao S, Conti DV,
Duggan D, Fuchs CS, Gala M, Gallinger S,
Haile RW, Harrison
TA,
Hayes R, Hazra A, Henderson B, Haiman C,
Hoffmeister M, Hopper JL,
Jenkins MA, Kolonel LN, Küry S, LaCroix A, Le
Marchand L, Lemire M,
Lindor NM, Ma J, Manson JE, Morikawa T, Nan H, Ng
K, Newcomb PA,
Nishihara R, Potter JD, Qu C, Schoen RE,
Schumacher FR, Seminara D,
Taverna D, Thibodeau S, Wactawski-Wende J, White
E, Wu K, Zanke BW,
Casey G, Hudson TJ, Kraft P, Peters U, Slattery
ML, Ogino S, Chan AT on
Behalf of GECCO and CCFR. Identification
of
a Common Variant with
Potential Pleiotropic Effect on Risk of
Inflammatory Bowel Disease and
Colorectal Cancer. Carcinogenesis
2015;36(9):999-1007
91. Thrift
AP, Gong J, Peters U, Chang-Claude J, Rudolph A,
Slattery ML, Chan AT,
Esko T, Wood AR, Yang J, Vedantam S, Gustafsson S,
Pers TH; GIANT
Consortium, Baron JA, Bezieau S, Küry S, Ogino S,
Berndt SI, Casey G,
Haile RW, Du M, Harrison TA, Thornquist M, Duggan
DJ, Le Marchand L,
Lemire M, Lindor NM, Seminara D, Song M, Thibodeau
SN, Cotterchio M,
Win AK, Jenkins MA, Hopper JL, Ulrich CM, Potter
JD, Newcomb PA, Schoen
RE, Hoffmeister M, Brenner H, White E, Hsu L,
Campbell PT. Mendelian
randomization
study of height and risk of colorectal cancer.
Int J
Epidemiol 2015; 44(2):662-72
90. Thrift AP, Gong J, Peters U,
Chang-Claude J, Rudolph A, Slattery ML, Chan AT,
Locke AE, Kahali B,
Justice AE, Pers TH, Gallinger S, Hayes RB, Baron
JA, Caan BJ, Ogino S,
Berndt SI, Chanock SJ, Casey G, Haile RW, Du M,
Harrison TA, Thornquist
M, Duggan DJ, Le Marchand L, Lindor NM, Seminara
D, Song M, Wu K,
Thibodeau SN, Cotterchio M, Win AK, Jenkins MA,
Hopper JL, Ulrich CM,
Potter JD, Newcomb PA, Hoffmeister M, Brenner H,
White E, Hsu L,
Campbell PT. Mendelian
randomization
study of body mass index and
colorectal cancer risk. Cancer Epidemiol
Biomarkers Prev
2015;24(7):1024-31
89. Kahlert C, Lerbs T, Pecqueux M, Herpel E,
Hoffmeister M, Jansen L, Brenner H, Chang-Claude
J, Bläker H, Kloor M,
Roth W, Pilarsky C, Rahbari NN, Schölch S, Bork U,
Reissfelder C, Weitz
J, Aust D, Koch M. Overexpression
of
SIX1 is an independent prognostic
marker in stage I-III colorectal cancer. Int
J Cancer
2015;137(9):2104-13
88. Nan H, Hutter CM, Lin Y, Jacobs EJ,
Ulrich CM, White E, Baron JA, Berndt SI, Brenner
H, Butterbach K, Caan
BJ, Campbell PT, Carlson CS, Casey G, Chang-Claude
J, Chanock SJ,
Cotterchio M, Duggan D, Figueiredo JC, Fuchs CS,
Giovannucci EL, Gong
J, Haile RW, Harrison TA, Hayes RB, Hoffmeister M,
Hopper JL, Hudson
TJ, Jenkins MA, Jiao S, Lindor NM, Lemire M, Le
Marchand L, Newcomb PA,
Ogino S, Pflugeisen BM, Potter JD, Qu C, Rosse SA,
Rudolph A, Schoen
RE, Schumacher FR, Seminara D, Slattery ML,
Thibodeau SN, Thomas F,
Thornquist M, Warnick GS, Zanke BW, Gauderman WJ,
Peters U, Hsu L, Chan
AT; CCFR and GECCO. Association
of
Aspirin and NSAID Use With Risk of
Colorectal Cancer According to Genetic Variants.
JAMA
2015;313(11):1133-42
87. Kap EJ, Seibold P, Richter S, Scherer
D, Habermann N, Balavarca Y, Jansen L, Becker N,
Pfütze K, Popanda O,
Hoffmeister M, Ulrich A, Benner A, Ulrich CM,
Burwinkel B, Brenner H,
Chang-Claude J. Genetic
variants
in DNA repair genes as potential
predictive markers for oxaliplatin chemotherapy
in colorectal cancer.
Pharmacogenomics J 2015;15(6):505-12
86. Hoffmeister M, Jansen
L, Rudolph A, Toth C, Kloor M, Roth W, Bläker H,
Chang-Claude J,
Brenner H. Statin
use
and survival after colorectal cancer: the
importance of comprehensive confounder
adjustment. J Natl
Cancer Inst
2015;107(6):djv045
85. Walter V, Jansen L, Hoffmeister M, Ulrich
A, Chang-Claude J, Brenner H. Smoking
and
survival of colorectal cancer
patients: Population-based study from Germany.
Int J Cancer
2015;137(6):1433-45
84. Hsu L, Jeon J, Brenner H, Gruber SB,
Schoen RE, Berndt SI, Chan AT, Chang-Claude J, Du
M, Gong J, Harrison
TA, Hayes RB, Hoffmeister M, Hutter CM, Lin Y,
Nishihara R, Ogino S,
Prentice RL, Schumacher FR, Seminara D, Slattery
ML, Thomas DC,
Thornquist M, Newcomb PA, Potter JD, Zheng Y,
White E, Peters U;
Colorectal Transdisciplinary (CORECT) Study and
Genetics and
Epidemiology of Colorectal Cancer Consortium
(GECCO). A
Model
to
Determine Colorectal Cancer Risk Using Common
Genetic Susceptibility
Loci. Gastroenterology 2015;148(7):1330-1339
83.
Song M, Gong J, Giovannucci EL, Berndt SI, Brenner
H, Chang-Claude J,
Curtis KR, Harrison TA, Hoffmeister M, Hsu L, Jiao
S, Le Marchand L,
Potter JD, Schoen RE, Seminara D, Slattery ML,
White E, Wu K, Ogino S,
Fuchs CS, Hunter DJ, Tworoger SS, Hu FB, Rimm E,
Jensen M, Peters U,
Chan AT. Genetic
variants
of adiponectin and risk of colorectal cancer.
Int J Cancer 2015;137(1):154-64
82.
Ananthakrishnan AN, Du M, Berndt SI, Brenner H,
Caan BJ, Casey G,
Chang-Claude J, Duggan D, Fuchs CS, Gallinger S,
Giovannucci EL,
Harrison TA, Hayes RB, Hoffmeister M, Hopper JL,
Hou L, Hsu L, Jenkins
MA, Kraft P, Ma J, Nan H, Newcomb PA, Ogino S,
Potter JD, Seminara D,
Slattery ML, Thornquist M, White E, Wu K, Peters
U, Chan AT. Red
Meat
Intake, NAT2, and Risk of Colorectal Cancer: A
Pooled Analysis of 11
Studies. Cancer Epidemiol Biomarkers Prev
2015;24(1):198-205
81.
Bläker H, Hildebrandt B,
von Winterfeld M, Ingold-Heppner B, Jansen L, Roth
W, Kloor M,
Schirmacher P, Dietel M, Tao S, Jansen L,
Chang-Claude J, Brenner H,
Hoffmeister M. Lymph
node
count and prognosis in colorectal cancer: the
influence of examination quality. Int J
Cancer
2015;136(8):1957-66
80. Bickeböller M,
Tagscherer KE, Kloor M, Jansen L,
Chang-Claude J, Brenner H, Hoffmeister M, Toth C,
Schirmacher P, Roth
W, Bläker H. Functional
characterization
of the tumor suppressor MARCKS
in colorectal cancer.
Oncogene 2015;34(9):1150-9
2014
79. Ristau
J, Staffa J, Schrotz-King P, Gigic B, Makar KW,
Hoffmeister M, Brenner
H, Ulrich A, Schneider M, Ulrich CM, Habermann N.
Suitability
of
circulating
miRNAs as potential prognostic markers in
colorectal
cancer. Cancer Epidemiol Biomark Prev
2014;23(12):2632–7
78.
Rudolph A, Shi H,
Försti A, Hoffmeister M, Sainz J, Jansen L,
Hemminki K, Brenner H,
Chang-Claude J. Repeat
polymorphisms
in ESR2 and AR and colorectal
cancer risk and prognosis: results from a German
population-based
case-control study. BMC Cancer 2014;14:817
77.
von Winterfeld M*, Hoffmeister M*, Ingold-Heppner
B, Jansen L, Tao S,
Herpel E, Schirmacher P, Dietel M, Chang-Claude J,
Brenner H, Bläker H
(*equal contribution). Frequency
of
therapy-relevant staging shifts in
CRC through the introduction of pN1c in the 7th
TNM edition.
Eur J
Cancer 2014;50(17):2958-65
76. Du M, Zhang X, Hoffmeister M, Schoen RE, Baron
J,
Berndt SI, Brenner H, Carlson CS, Casey G, Chan
AT, Curtis KR, Duggan
D, Gauderman WJ, Giovannucci EL, Gong J, Harrison
TA, Hayes RB,
Henderson BE, Hopper JL, Hsu L, Hudson TJ, Hutter
CM, Jenkins MA, Jiao
S, Kocarnik JM, Kolonel LN, Le Marchand L, Lin Y,
Newcomb PA, Rudolph
A, Seminara D, Thornquist M, Ulrich CM, White E,
Wu K, Zanke BW,
Campbell PT, Slattery ML, Peters U, Chang-Claude
J, Potter JD. No
evidence
of gene-calcium interactions from genome-wide
analysis of
colorectal cancer risk. Cancer Epidemiol
Biomarkers Prev
2014;(12):2971-6
75. Stenzinger A, Pfarr N, Endris V,
Penzel R, Jansen L, Wolf T, Herpel E, Warth A,
Klauschen F, Kloor M,
Roth W, Bläker H, Chang-Claude J, Brenner H,
Hoffmeister M, Weichert W.
Mutations
in
POLE and survival of colorectal cancer patients
- link to
disease stage and treatment. Cancer Med
2014; 3(6):1527-38
74.
Wang H, Burnett T, Kono S, Haiman CA, Iwasaki M,
Wilkens LR, Loo LW,
Van Den Berg D, Kolonel LN, Henderson BE, Keku TO,
Sandler RS,
Signorello LB, Blot WJ, Newcomb PA, Pande M, Amos
CI, West DW, Bézieau
S, Berndt SI, Zanke BW, Hsu L; GECCO consortium
members:, Lindor NM,
Haile RW, Hopper JL, Jenkins MA, Gallinger S,
Casey G; CCFR consortium
members:, Stenzel SL, Schumacher FR, Peters U,
Gruber SB; CORECT
consortium members:, Tsugane S, Stram DO, Le
Marchand L; GECCO
consortium members; CCFR consortium members;
CORECT consortium members.
Trans-ethnic
genome-wide
association study of colorectal cancer
identifies a new susceptibility locus in VTI1A.
Nat Commun
2014;5:4613
73. Brenner H, Chang-Claude J, Jansen L, Stock C,
Hoffmeister M. Reply:
Reduced
risk of colorectal cancer up to 10 years
after screening, surveillance, or diagnostic
colonoscopy.
Gastroenterology 2014;147(3):717-8
72. Kantor ED,
Hutter CM, Minnier J, Berndt SI, Brenner H, Caan
BJ, Campbell PT,
Carlson CS, Casey G, Chan AT, Chang-Claude J,
Chanock SJ, Cotterchio M,
Du M, Duggan D, Fuchs CS, Giovannucci EL, Gong J,
Harrison TA, Hayes
RB, Henderson BE, Hoffmeister M, Hopper JL,
Jenkins MA, Jiao S, Kolonel
LN, Le Marchand L, Lemire M, Ma J, Newcomb PA,
Ochs-Balcom HM,
Pflugeisen BM, Potter JD, Rudolph A, Schoen RE,
Seminara D, Slattery
ML, Stelling DL, Thomas F, Thornquist M, Ulrich
CM, Warnick GS, Zanke
BW, Peters U, Hsu L, White E. Gene-environment
interaction
involving
recently identified colorectal cancer
susceptibility loci.
Cancer
Epidemiol Biomarkers Prev 2014;23(9):1824-33
71. Kap L,
Richter S, Rudolph A, Jansen L, Ulrich A,
Hoffmeister M, Ulrich CM,
Brenner H, Chang-Claude J. Genetic
variants
in the GST genes and
survival in CRC patients treated with
chemotherapy and differences
according to treatment with oxaliplatin.
Pharmacogenet
Genomics
2014;24(7):340-7
70. Zhang B, Jia WH, Matsuda K, Kweon
SS, Matsuo K, Xiang YB, Shin A, Jee SH, Kim DH,
Cai Q, Long J, Shi J,
Wen W, Yang G, Zhang Y, Li C, Li B, Guo Y, Ren Z,
Ji BT, Pan ZZ,
Takahashi A, Shin MH, Matsuda F, Gao YT, Oh JH,
Kim S, Ahn YO; Genetics
and Epidemiology of Colorectal Cancer Consortium
(GECCO), Chan AT,
Chang-Claude J, Slattery ML; Colorectal
Transdisciplinary (CORECT)
Study, Gruber SB, Schumacher FR, Stenzel SL; Colon
Cancer Family
Registry (CCFR), Casey G, Kim HR, Jeong JY, Park
JW, Li HL, Hosono S,
Cho SH, Kubo M, Shu XO, Zeng YX, Zheng W. Large-scale
genetic
study in
East Asians identifies six new loci associated
with colorectal cancer
risk. Nat Genet 2014;46(6):533-42
69. Figueiredo JC,
Hsu L, Hutter CM, Lin Y, Campbell PT, Baron JA,
Berndt SI, Jiao S,
Casey G, Fortini B, Chan AT, Cotterchio M, Lemire
M, Gallinger S,
Harrison TA, Le Marchand L, Newcomb PA, Slattery
ML, Caan BJ, Carlson
CS, Zanke BW, Rosse SA, Brenner H, Giovannucci EL,
Wu K, Chang-Claude
J, Chanock SJ, Curtis KR, Duggan D, Gong J, Haile
RW, Hayes RB,
Hoffmeister M, Hopper JL, Jenkins MA, Kolonel LN,
Qu C, Rudolph A,
Schoen RE, Schumacher FR, Seminara D, Stelling DL,
Thibodeau SN,
Thornquist M, Warnick GS, Henderson BE, Ulrich CM,
Gauderman WJ, Potter
JD, White E, Peters U; CCFR; GECCO. Genome-wide
diet-gene
interaction
analyses for risk of colorectal cancer. PLoS
Genet
2014;10(4):e1004228
68. Dihlmann S*, Tao S*, Echterdiek F, Herpel E,
Jansen
L, Chang-Claude J, Brenner H, Hoffmeister M**,
Kloor M** (*,** equal
contribution). Lack
of
Absent
in Melanoma 2 (AIM2) expression in tumor
cells is closely associated with poor survival
in colorectal cancer
patients. Int J Cancer 2014;135(10):2387-96
67. Sainz
J, Frank B, da Silva Filho MI, Hoffmeister M,
Rudolph A, Butterbach K,
Chang-Claude J, Brenner H, Hemminki K, Försti A. GWAS-Identified
Common
Variants
for Obesity Are Not Associated with the Risk of
Developing
Colorectal Cancer. Cancer Epidemiol
Biomarkers Prev
2014;23(6):1125-8
66.
Jiao S, Peters U, Berndt S, Brenner H, Butterbach
K, Caan BJ, Carlson
CS, Chan AT, Chang-Claude J, Chanock S, Curtis KR,
Duggan D, Gong J,
Harrison TA, Hayes RB, Henderson BE, Hoffmeister
M, Kolonel LN,
Marchand LL, Potter JD, Rudolph A, Schoen RE,
Seminara D, Slattery ML,
White E, Hsu L. Estimating
the
heritability of colorectal cancer. Hum
Mol Genet 2014;23(14):3898-905
65. Jansen L,
Hoffmeister M, Arndt V, Chang-Claude J, Brenner H.
Stage-specific
associations
between beta blocker use and prognosis after
colorectal
cancer. Cancer 2014;120(8):1178-86
64. Hoffmeister M,
Jansen L, Stock C, Chang-Claude J, Brenner H. Smoking,
lower
gastrointestinal
endoscopy, and risk for colorectal cancer.
Cancer
Epidemiol Biomarkers Prev 2014;23(3):525-33
2013
63.
Hoffmeister M*, Bläker H*, Kloor M, Roth W, Toth
C, Herpel E, Frank B,
Schirmacher P, Chang-Claude J, Brenner H (*equal
contribution). Body
mass
index and microsatellite instability in
colorectal cancer: a
population-based case-control study. Cancer
Epidem Biomarkers
Prev
2013;22(12):2303-11
62. Perna L, Hoffmeister M,
Schöttker B, Arndt V, Haug U, Holleczek B,
Burwinkel B, Ordóñez-Mena
JM, Brenner H. Vitamin
D
receptor
polymorphism and colorectal
cancer-specific and all-cause mortality.
Cancer Epidemiol
2013;37(6):905-7
61. Picelli S, Lorenzo Bermejo J,
Chang-Claude J, Hoffmeister M, Fernández-Rozadilla
C, Carracedo A,
Castells A, Castellví-Bel S; Members of the
EPICOLON Consortium
(Gastrointestinal Oncology Group of the Spanish
Gastroenterological
Association):, Naccarati A, Pardini B, Vodickova
L, Müller H,
Talseth-Palmer BA, Stibbard G, Peterlongo P, Nici
C, Veneroni S, Li L,
Casey G, Tenesa A, Farrington SM, Tomlinson I,
Moreno V, van Wezel T,
Wijnen J, Dunlop M, Radice P, Scott RJ, Vodicka P,
Ruiz-Ponte C,
Brenner H, Buch S, Völzke H, Hampe J, Schafmayer
C, Lindblom A.
Meta-Analysis
of
mismatch repair polymorphisms within the Cogent
consortium for colorectal cancer susceptibility.
PLOS One.
2013;8(9):e72091
60. Brenner H, Chang-Claude J, Jansen
L, Knebel P, Stock C, Hoffmeister M. Reduced
risk
of colorectal cancer
up to 10 y after screening, surveillance, or
diagnostic colonoscopy.
Gastroenterology 2013;146(3);709-17
59. Hiraki LT, Qu
C, Hutter CM, Baron J, Berndt SI, Bezieau S,
Brenner H, Caan BJ, Casey
G, Chang-Claude J, Chanock SJ, Conti DV, Duggan D,
Fuchs CS, Gallinger
S, Giovannucci EL, Harrison TA, Hayes RB, Hazra A,
Henderson B,
Hoffmeister M, Hopper JL, Hudson TJ, Jenkins MA,
Küry S, Le Marchand L,
Lemire M, Ma J, Manson JE, Nan H, Newcomb PA, Ng
K, Potter JD, Schoen
RE, Schumacher F, Seminara D, Slattery ML,
Wactawski-Wende J, White E,
Wu K, Zanke BW, Kraft P, Peters U, Chan AT. Genetic
predictors
of
circulating 25-hydroxyvitamin D and risk of
colorectal cancer.
Cancer
Epidemiol Biomarkers Prev 2013;22(11):2037-46
58.
Cheng I, Kocarnik JM, Dumitrescu L, Lindor NM,
Chang-Claude J, Avery
CL, Caberto CP, Love SA, Slattery ML, Chan AT,
Baron JA, Hindorff LA,
Park SL, Schumacher FR, Hoffmeister M, Kraft P,
Butler AM, Duggan DJ,
Hou L, Carlson CS, Monroe KR, Lin Y, Carty CL,
Mann S, Ma J,
Giovannucci EL, Fuchs CS, Newcomb PA, Jenkins MA,
Hopper JL, Haile RW,
Conti DV, Campbell PT, Potter JD, Caan BJ, Schoen
RE, Hayes RB, Chanock
SJ, Berndt SI, Küry S, Bézieau S, Ambite JL,
Kumaraguruparan G,
Richardson DM, Goodloe RJ, Dilks HH, Baker P,
Zanke BW, Lemire M,
Gallinger S, Hsu L, Jiao S, Harrison TA, Seminara
D, Haiman CA,
Kooperberg C, Wilkens LR, Hutter CM, White E,
Crawford DC, Heiss G,
Hudson TJ, Brenner H, Bush WS, Casey G, Le
Marchand L, Peters U.
Pleiotropic
effects
of genetic risk variants for other cancers on
colorectal cancer risk: PAGE, GECCO, and CCFR
Consortia. Gut
2013;63(5):800-7
57. Brenner H, Chang-Claude J,
Jansen L, Seiler CM, Hoffmeister M. Colorectal
cancers
occurring after
colonoscopy with polyp detection: sites of
polyps and sites of cancers.
Int J Cancer 2013;133(7):1672-9
56. Funke V*, Lehmann
J*, Bickeböller M*, Benner A, Tagscherer KE, Grund
K, Pfeifer M, Herpel
E, Schirmacher P, Chang-Claude J, Brenner H,
Hoffmeister M, Roth W
(*these authors contributed equally). The
PEA-15/PED
protein regulates
cellular survival and invasiveness in
colorectal carcinomas.
Cancer Lett 2013;335(2):431-40
55. Rudolph A, Toth C,
Hoffmeister M, Roth W, Herpel E, Schirmacher P,
Brenner H, Chang-Claude
J. Colorectal
cancer
risk associated with hormone use varies by
expression of estrogen receptor beta. Cancer
Res
2013;73(11):3306-15
54. Ulrich CM, Toriola AT, Siegel EM, Brenner H,
Chang-Claude J, Abbenhardt C, Kotzmann J, Song X,
Owen RW, Hoffmeister
M, Becher H, Shibata D, Vickers K, Rush SK, Makar
K, Würtele G, Haubner
R, Sellers TA, Grady W on behalf of the ColoCare
Consortium. Plasma
25(OH)D3,
folate, and vitamin B12 biomarkers among
international
colorectal cancer patients: a pilot study. J
Nutr Sci
2013;2:e9
53. Brenner H, Chang-Claude J, Hoffmeister M. Re:
Colonoscopy
and polyp characteristics. Ann Int Med
2013;158(2):142
52.
Peters U, Jiao S, Schumacher FR, Hutter CM,
Aragaki AK, Baron JA,
Berndt SI, Bézieau S, Brenner H, Butterbach K,
Caan BJ, Campbell PT,
Carlson CS, Casey G, Chan AT, Chang-Claude J,
Chanock SJ, Chen LS,
Coetzee GA, Coetzee SG, Conti DV, Curtis KR,
Duggan D, Edwards T, Fuchs
CS, Gallinger S, Giovannucci EL, Gogarten SM,
Gruber SB, Haile RW,
Harrison TA, Hayes RB, Henderson BE, Hoffmeister
M, Hopper JL, Hudson
TJ, Hunter DJ, Jackson RD, Jee SH, Jenkins MA, Jia
WH, Kolonel LN,
Kooperberg C, Küry S, Lacroix AZ, Laurie CC,
Laurie CA, Le Marchand L,
Lemire M, Levine D, Lindor NM, Liu Y, Ma J, Makar
KW, Matsuo K, Newcomb
PA, Potter JD, Prentice RL, Qu C, Rohan T, Rosse
SA, Schoen RE,
Seminara D, Shrubsole M, Shu XO, Slattery ML,
Taverna D, Thibodeau SN,
Ulrich CM, White E, Xiang Y, Zanke BW, Zeng YX,
Zhang B, Zheng W, Hsu
L; Colon Cancer Family Registry (CCFR) and
Genetics and Epidemiology of
Colorectal Cancer Consortium (GECCO). Identification
of
genetic
susceptibility loci for colorectal tumors in a
genome-wide
meta-analysis. Gastroenterology
2013;144(4):799-807
51.
Dunlop MG,
Tenesa A, Farrington SM, Ballereau S, Brewster DH,
Kossler T, Pharoah
P, Schafmayer C, Hampe J, Völzke H, Chang-Claude
J, Hoffmeister M,
Brenner H, von Holst S, Picelli S, Lindblom A,
Jenkins MA, Hopper JL,
Casey G, Duggan D, Newcomb PA, Abulí A, Bessa X,
Ruiz-Ponte C,
Castellví-Bel S, Niittymäki I, Tuupanen S, Karhu
A, Aaltonen L, Zanke
B, Hudson T, Gallinger S, Barclay E, Martin L,
Gorman M,
Carvajal-Carmona L, Walther A, Kerr D, Lubbe S,
Broderick P, Chandler
I, Pittman A, Penegar S, Campbell H, Tomlinson I,
Houlston RS.
Cumulative
impact
of 10 common genetic variants on colorectal
cancer
risk in 39,266 individuals from seven
populations. Gut
2013;62(6):871-81
2012
50.
Jiao S, Hsu L, Berndt S, Bézieau S,
Brenner H, Buchanan D, Caan BJ, Campbell PT,
Carlson CS, Casey G, Chan
AT, Chang-Claude J, Chanock S, Conti DV, Curtis
KR, Duggan D, Gallinger
S, Gruber SB, Harrison TA, Hayes RB, Henderson BE,
Hoffmeister M,
Hopper JL, Hudson TJ, Hutter CM, Jackson RD,
Jenkins MA, Kantor ED,
Kolonel LN, Küry S, Le Marchand L, Lemire M,
Newcomb PA, Potter JD, Qu
C, Rosse SA, Schoen RE, Schumacher FR, Seminara D,
Slattery ML, Ulrich
CM, Zanke BW, Peters U. Genome-wide
search
for gene-gene interactions
in colorectal cancer. PLOS One
2012;7(12):e52535
49.
Huhn S, Bevier M, Rudolph A, Pardini B, Naccarati
A, Hein R,
Hoffmeister M, Vodickova L, Novotny J, Brenner H,
Chang-Claude J,
Vodicka P, Hemminki K, Försti A. Shared
ancestral
susceptibility to
colorectal cancer and other nutrition related
diseases. BMC
Med Genet
2012;13(1):94
48. Brenner H, Chang-Claude J, Jansen
L, Seiler CM, Hoffmeister M. Role
of
colonoscopy and polyp
characteristics in colorectal cancer after
colonoscopic polyp
detection: a population-based case-control study.
Ann Int Med
2012;157(4):225-32
47. Brenner H, Chang-Claude J,
Rickert A, Seiler CM, Hoffmeister M. Risk
of
colorectal cancer after
detection and removal of adenomas at
colonoscopy: population-based
case-control study. J Clin Oncol
2012;30(24):2969-76
46.
Kahlert C, Gaitzsch E, Steinert G, Rahbari N,
Schmidt T, Mogler C,
Herpel E, Hoffmeister M, Benner A, Brenner H,
Chang-Claude J, Klupp F,
Grabe N, Lahrmann B, Koch M, Halama N, Büchler M,
Weitz J. Expression
analysis
of aldehyde deyhdrogenase 1A1 (ALDH1A1) in colon
and rectal
cancer in association with prognosis and
response to chemotherapy.
Ann
Surg Oncol 2012;19(13):4193-201
45. Rudolph A, Toth
C, Hoffmeister M, Roth W, Herpel E, Jansen L, Marx
A, Brenner H,
Chang-Claude J. Expression
of
estrogen receptor beta and prognosis of
colorectal cancer. Brit J Cancer
2012;107(5):831-9
44.
Jansen L, Below J, Chang-Claude J, Brenner H,
Hoffmeister M. Beta
blocker
use and colorectal cancer risk: population-based
case-control
study. Cancer 2012;118(16):3911-9
43. Sainz J, Rudolph A, Hoffmeister M, Frank B,
Brenner H, Chang-Claude
J,
Hemminki
K, Försti A. Effect
of
type
2 diabetes predisposing genetic variants on
colorectal cancer risk. J Clin Endocrin
Metab
2012;97(5):E845-51
42. Campa D, Sainz J, Pardini B, Vodickova L,
Naccarati
A, Rudolph A, Novotny J, Försti A, Buch S, von
Schönfels W, Schafmayer
C, Völzke H, Hoffmeister M, Frank B, Barale R,
Hemminki K, Hampe J,
Chang-Claude J, Brenner H, Vodicka P, Canzian F. A
comprehensive
investigation on polymorphisms in the MDR1/ABCB1
transporter gene and
susceptibility to colorectal cancer. PLoS
One
2012;7(3):e32784
41. Zhang Y, Hoffmeister M, Weck MN, Chang-Claude
J, Brenner H.
Helicobacter
pylori
infection and colorectal cancer risk: evidence
from
a large population-based case-control study in
Germany. Am J
Epidemiol
2012;175(5):441-50
40. Hutter CM, Chang-Claude J,
Slattery ML, Pflugeisen BM, Lin Y, Duggan D, Nan
H, Lemire M, Rangrej
J, Figueiredo JC, Jiao S, Harrison TA, Liu Y, Chen
LS, Stelling DL,
Warnick GS, Hoffmeister M, Küry S, Fuchs CS,
Giovannucci E, Hazra A,
Kraft P, Hunter DJ, Gallinger S, Zanke BW, Brenner
H, Frank B, Ma J,
Ulrich CM, White E, Newcomb PA, Kooperberg C,
Lacroix AZ, Prentice RL,
Jackson RD, Schoen RE, Chanock SJ, Berndt SI,
Hayes RB, Caan BJ, Potter
JD, Hsu L, Bezieau S, Chan AT, Hudson TJ, Peters
U. Characterizing
gene-environment
interactions for previously identified
colorectal
cancer susceptibility loci. Cancer Res
2012;72(8):2036-44
39.
Rudolph A, Hein R, Hoffmeister M, Försti A,
Hemminki K, Risch A,
Brenner H, Chang-Claude J. Copy
number
variations of GSTT1 and GSTM1,
colorectal cancer risk and possible effect
modification of cigarette
smoking and menopausal hormone therapy. Int
J Cancer
2012;131(5):E841-8
38. Brenner H, Chang-Claude J, Seiler CM,
Hoffmeister
M. Interval
cancers
after negative colonsocopy: population-based
case-control study. Gut 2012;61(11):1576-82
37.
Peters U, Hutter CM, Hsu L,
Schumacher FR, Conti DV, Carlson CS, Edlund CK,
Haile RW, Gallinger S,
Zanke BW, Lemire M, Rangrej J, Vijayaraghavan R,
Chan AT, Hazra A,
Hunter DJ, Ma J, Fuchs CS, Giovannucci EL, Kraft
P, Liu Y, Chen L, Jiao
S, Makar KW, Taverna D, Gruber SB, Rennert G,
Moreno V, Ulrich CM,
Woods MO, Green RC, Parfrey PS, Prentice RL,
Kooperberg C, Jackson RD,
Lacroix AZ, Caan BJ, Hayes RB, Berndt SI, Chanock
SJ, Schoen RE,
Chang-Claude J, Hoffmeister M, Brenner H, Frank B,
Bézieau S, Küry S,
Slattery ML, Hopper JL, Jenkins MA, Le Marchand L,
Lindor NM, Newcomb
PA, Seminara D, Hudson TJ, Duggan DJ, Potter JD,
Casey G. Meta-analysis
of
new genome-wide association studies of
colorectal cancer risk.
Hum
Genet 2012;13:(2):217-34
2011
36.
Jansen L, Hoffmeister M, Chang-Claude J, Koch M,
Brenner H, Arndt V.
Age-specific
administration
of chemotherapy and long-term quality of
life in stage II and III colorectal cancer
patients - a
population-based prospective cohort.
Oncologist
2011;16(12):1742-51
35. Jansen L, Hoffmeister M, Chang-Claude J,
Brenner H,
Arndt A. Benefit
finding
and posttraumatic growth in long-term
colorectal cancer survivors: prevalence,
determinants, and associations
with quality of life. Brit J Cancer
2011;105(8):1158-65
34.
Brenner H, Chang-Claude J, Seiler CM, Hoffmeister
M. Long-term
risk
of
colorectal cancer after negative colonoscopy.
J Clin Oncol
2011;29(28):3761-7
33. Brenner H, Chang-Claude
J, Hoffmeister M. Re:
Colonoscopy
prevents colorectal cancer in both
the right and left colon. Gastroenterology
2011;141(1):396
32. Rudolph A, Sainz J, Hein R, Hoffmeister M,
Frank
B, Brenner H, Försti A, Hemminki K, Chang-Claude
J. Modification
of
menopausal
hormone therapy associated colorectal cancer
risk by genetic
polymorphisms in sex steroid signaling,
metabolism and transport
related genes. Endocr Relat Cancer
2011;18(3):371-84
31.
Vossen CY, Hoffmeister M, Chang-Claude J,
Rosendaal FR, Brenner H.
Clotting
factor
gene polymorphisms and colorectal cancer risk.
J Clin
Oncol, 2011;29(13):1722-7
30. Sainz J*, Rudolph A*,
Hein R, Hoffmeister M, Buch S, Hampe J, Schafmayer
C, Frank B, Brenner
H, Försti A, Hemminki K, Chang-Claude J. Association
of
genetic
polymorphisms in ESR2, HSD17B1, ABCB1 and SHBG
genes with colorectal
cancer risk. Endocr Relat Cancer
2011;18(2):265-76 (*authors
contributed equally to this work)
29. Frank B, Hoeft
B, Hoffmeister M, Linseisen J, Breitling LP,
Chang-Claude J, Brenner H,
Nieters A. Association
of
hydroxyprostaglandin dehydrogenase 15-(NAD)
(HPGD) variants and colorectal cancer risk.
Carcinogenesis
2011;31(2):190-6
28. Brenner H, Chang-Claude J,
Seiler CM, Rickert A, Hoffmeister M. Protection
from
colorectal cancer
after colonoscopy: population-based case-control
study. Ann
Intern Med
2011;154(1):22-30
2010
27. Lascorz J, Försti A,
Chen B, Buch S, Kunkel N, Weires M, Hoffmeister M,
Pardini B, Naccarati
A, Vodickova L, Novotny J, German HNPCC
Consortium, Schafmayer C,
Vodicka P, Chang-Claude J, Brenner H, Burwinkel B,
Propping P, Hampe J,
Hemminki K. Genome-wide
association
study for colorectal cancer
identifies risk polymorphisms in German familial
cases, and implicates
MAPK signalling pathways in disease
susceptibility.
Carcinogenesis
2010;31(9):1612-9
26. Frank B, Hoffmeister M, Klopp
N, Illig T, Chang-Claude J, Brenner H. Single
nucleotide
polymorphisms
in Wnt signaling and cell death pathway genes
and susceptibility to
colorectal cancer. Carcinogenesis
2010;31(8):1381-6
25.
Frank B, Hoffmeister M, Klopp N, Illig T,
Chang-Claude J, Brenner H.
Polymorphisms
in
inflammatory pathway genes and their association
with
colorectal cancer risk. Int J Cancer
2010;127(12):2822-30
24.
Frank B, Hoffmeister M, Klopp N, Illig T,
Chang-Claude J, Brenner H.
Colorectal
cancer
and polymorphisms in DNA repair genes WRN, RMI1,
and
BLM. Carcinogenesis 2010;31(3):442-5
23. Funke S,
Risch A, Hoffmeister M, Stegmaier C, Seiler CM,
Brenner H, Chang-Claude
J. Genetic
polymorphisms
in GST genes and survival of colorectal cancer
patients treated with chemotherapy.
Pharmacogenomics
2010;11(1):33-41
2009
22. Funke S, Risch A, Nieters A, Hoffmeister M,
Stegmaier C, Seiler CM, Brenner H, Chang-Claude J.
Genetic
polymorphisms
in genes related to oxidative stress (GSTP1,
GSTM1,
GSTT1, CAT, MnSOD, MPO, eNOS) and survival of
rectal cancer patients
after radiation therapy. J Cancer Epidemiol
2009;
doi:10.1155/2009/302047
21. Hoffmeister M, Raum E,
Krtschil A, Chang-Claude J, Brenner H. No
evidence
for variation in
colorectal cancer risk associated with different
types of
postmenopausal hormone therapy. Clin
Pharmacol Ther
2009;86(4):416-24
20. Funke S, Hoffmeister M, Brenner H,
Chang-Claude J.
Effect
modification
by smoking on the association between genetic
polymorphisms in oxidative stress genes and
colorectal cancer risk.
Cancer Epidemiol Biomark Prev 2009;18(8):2336-8
19.
Verla-Tebit E, Lilla C, Hoffmeister M, Brenner H,
Chang-Claude J.
Exposure
to
environmental tobacco smoke and the risk of
colorectal
cancer in a case-control study from Germany.
Eur J Cancer
Prev
2009;18(1):9-12
2008
18. Houlston RS, Webb E, Broderick P,
Pittman AM, Di Bernardo MC, Lubbe S, Chandler I,
Vijayakrishnan J,
Sullivan K, Penegar S; Colorectal Cancer
Association Study Consortium,
Carvajal-Carmona L, Howarth K, Jaeger E, Spain SL,
Walther A, Barclay
E, Martin L, Gorman M, Domingo E, Teixeira AS;
CoRGI Consortium, Kerr
D, Cazier JB, Niittymäki I, Tuupanen S, Karhu A,
Aaltonen LA, Tomlinson
IP, Farrington SM, Tenesa A, Prendergast JG,
Barnetson RA, Cetnarskyj
R, Porteous ME, Pharoah PD, Koessler T, Hampe J,
Buch S, Schafmayer C,
Tepel J, Schreiber S, Völzke H, Chang-Claude J,
Hoffmeister M, Brenner
H, Zanke BW, Montpetit A, Hudson TJ, Gallinger S;
International
Colorectal Cancer Genetic Association Consortium,
Campbell H, Dunlop
MG. Meta-analysis
of
genome-wide association data identifies four new
susceptibility loci for colorectal cancer.
Nat Genet
2008;40(12):1426-35
17. Tenesa A, Farrington SM,
Prendergast JGD, Porteous ME, Walker M, Haq N,
Barnetson RA,
Theodoratou E, Cetnarskyj R, Cartwright N, Wilson
R, Clarke AJ, Reid
FJL, Smith LA, Kavoussanakis K, Kossler T, Pharoah
PDP, Buch S,
Schafmayer C, Tepel J, Schreiber S, Völzke H,
Schmidt CO, Hampe J,
Wilkening S, Canzian F, Chang-Claude J,
Hoffmeister M, Brenner H,
Capella G, Moreno V, Deary IJ, Starr JM, Tomlinson
IPM, Webb E,
Houlston RS, Rennert G, Ballinger D, Rozek L,
Gruber SB, Matsuda K,
Kidokoro T, Nakamura Y, Zanke BW, Greenwood MTW,
Rangrej J, Kustra R,
Montpetit A, Gallinger S, Hudson TJ, Campbell H,
Dunlop MG. A
genome-wide association scan identifies a
colorectal cancer
susceptibility locus on 11q23 and replicates
risk loci at 8q24 and
18q21. Nat Genet 2008;40(5):631-7
16. Tan XL, Nieters
A, Kropp S, Hoffmeister M, Brenner H, Chang-Claude
J. The
association
of
cyclin D1 G870A and E-cadherin C160A
polymorphisms with the risk of
colorectal cancer in a case-control study and
meta-analysis.
Int J
Cancer 2008;122(11):2573-80
2007
15. Pechlivanis S, Wagner
K, Chang-Claude J, Hoffmeister M, Brenner H,
Försti A. Polymorphisms
in
the
insulin like growth factor 1 and IGF binding
protein 3 genes and
risk of colorectal cancer. Cancer Detect
Prev
2007;31(5):408-16
14.
Hoffmeister M, Raum E, Winter J, Chang-Claude J,
Brenner H. Hormone
replacement
therapy, body mass and the risk of colorectal
cancer among
postmenopausal women from Germany. Brit J
Cancer
2007;97(11):1486-92
13. Tan XL, Nieters A, Hoffmeister M, Beckmann L,
Brenner H, Chang-Claude J. Genetic
Polymorphisms
in TP53, Nonsteroidal
Anti-inflammatory Drugs and the Risk of
Colorectal Cancer: Evidence for
Gene-Environment Interaction? Pharmacogenet
Genomics 2007,
17(8):639-45
12. Hoffmeister M, Chang-Claude J, Brenner H.
Individual
and
joint use of statins and low-dose aspirin and
risk of
colorectal cancer: a population-based
case-control study. Int
J Cancer
2007;121(6):1325-30
11. Hoffmeister M, Chang-Claude
J, Brenner H. Validity
of
self-reported endoscopies of the large bowel
and implications for estimates of colorectal
cancer risk. Am
J
Epidemiol 2007;166(2):130-6
10. Zumkeller N, Brenner
H, Chang-Claude J, Hoffmeister M, Nieters A,
Rothenbacher D.
Helicobacter
pylori
infection, interleukin-1 gene polymorphisms and
the
risk of colorectal cancer: evidence from a
case-control study in
Germany. Eur J Cancer 2007;43(8):1283-9
9. Brenner H,
Chang-Claude J, Seiler CM, Stürmer T, Hoffmeister
M. Case-control
study
supports
five-year interval for surveillance colonoscopy
after
polypectomy outside special risk groups. Am
J Gastroenterol
2007;102(8):1739-44
8. Shanmugam KS, Brenner H,
Hoffmeister M, Chang-Claude J, Burwinkel B. The
functional
genetic
variant Arg324Gly of secreted frizzled-related
protein 3 (FRZB) is
associated with colorectal cancer risk.
Carcinogenesis
2007;28(9):1914-7
7. Brenner H, Chang-Claude J,
Seiler CM, Stürmer T, Hoffmeister M. Potential
for
colorectal cancer
prevention of sigmoidoscopy versus colonoscopy:
population-based
case-control study. Cancer Epidemiol
Biomarkers Prev
2007;16(3):494-9
6. Frank B, Shanmugam KL, Hemminki K, Brenner H,
Hoffmeister M, Chang-Claude J, Burwinkel B. Death
receptor
4 haplotype
626C-683C is associated with an increased risk
of colorectal cancer.
Cancer Epidemiol Biomark Prev 2006;15(10):2002-5
5.
Lilla C, Verla-Tebit E, Risch A, Jäger B,
Hoffmeister M, Brenner H,
Chang-Claude J. SULT1A1
genotype
and susceptibility to colorectal
cancer. Int J Cancer 2007;120(1):201-6
2006
4. Verla-Tebit
E, Lilla C, Hoffmeister M, Brenner H, Chang-Claude
J. Cigarette
smoking
and
colorectal cancer risk in Germany: A
population-based case-control
study. Int J Cancer 2006;119(3):630-5
3. Frank B,
Hemminki K, Brenner H, Hoffmeister M, Chang-Claude
J, Burwinkel B.
ARLTS1
variants
and risk of colorectal cancer. Cancer Lett
2006;244(2):172-5
2.
Brenner H, Chang-Claude J, Seiler
CM, Stürmer T, Hoffmeister M. Does
a
negative screening colonoscopy
ever need to be repeated? Gut
2006;55(8):1145-50
1. Lilla C, Verla-Tebit E, Risch A, Jäger B,
Hoffmeister M, Brenner H,
Chang-Claude J. Effect
of
NAT1 and NAT2 genetic polymorphisms on
colorectal cancer risk
associated with exposure to tobacco smoke and
meat consumption.
Cancer Epidemiol Biomark Prev 2006;15(1):99-107
|
|
